Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (24303)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2016 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang CY, Yuan WG, He P, Lei JH, Wang CX. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol 2016; 22(48): 10512-10522 [PMID: 28082803 DOI: 10.3748/wjg.v22.i48.10512] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i48/10512.htm |
| Number | Citing Articles |
| 1 |
Kumar Jayant, Nagy Habib, Kai W. Huang, Jane Warwick, Ramesh Arasaradnam. Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma. Diagnostics 2020; 10(5): 338 doi: 10.3390/diagnostics10050338
|
| 2 |
Li Li, Jianghua Ran, Lan Li, Gang Chen, Shengning Zhang, Yingjia Wang. Gli3 is a novel downstream target of miR‑200a with an anti‑fibrotic role for progression of liver fibrosis in�vivo and in�vitro. Molecular Medicine Reports 2020; doi: 10.3892/mmr.2020.10997
|
| 3 |
Xiaoshan Wu, Dacheng Jiang, Yi Yang, Shuang Li, Qiurong Ding. Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids. Cell Regeneration 2023; 12(1) doi: 10.1186/s13619-022-00148-1
|
| 4 |
Abdullah Ahmed Gibriel, Manal Fouad Ismail, Hameis Sleem, Naglaa Zayed, Ayman Yosry, Saeed M. El-Nahaas, Nagwa Ibrahim Shehata. Diagnosis and staging of HCV associated fibrosis, cirrhosis and hepatocellular carcinoma with target identification for miR-650, 552-3p, 676-3p, 512-5p and 147b. Cancer Biomarkers 2022; 34(3): 413 doi: 10.3233/CBM-210456
|
| 5 |
Yan-Ming Bai, Shuang Liang, Bo Zhou. Yangyinghuoxue decoction exerts a treatment effect on hepatic fibrosis by PI3K/AKT pathway in rat model: based on the network pharmacology and molecular docking. Aging 2024; 16(4): 3773 doi: 10.18632/aging.205559
|
| 6 |
Shu Dong, Xian Miao, Ke Zhang, Xiaoyan Zhu, Yi Gao, Hao Chen. Elastic modulus-reflected liver lesion stiffness relates to worse prognosis in pancreatic cancer patients with liver metastasis. World Journal of Surgical Oncology 2023; 21(1) doi: 10.1186/s12957-023-03140-4
|
| 7 |
Haina Xie, Dongyu Xie, Jingxian Zhang, Wenye Jin, Yue Li, Jun Yao, Zhiqiang Pan, Donghao Xie. ROS/NF-κB Signaling Pathway-Mediated Transcriptional Activation of TRIM37 Promotes HBV-Associated Hepatic Fibrosis. Molecular Therapy - Nucleic Acids 2020; 22: 114 doi: 10.1016/j.omtn.2020.08.014
|
| 8 |
Binbin Li, Jiaming Zhou, Yuanyuan Luo, Kegong Tao, Lifen Zhang, Ying Zhao, Yong Lin, Xin Zeng, Hongyu Yu. Suppressing circ_0008494 inhibits HSCs activation by regulating the miR-185-3p/Col1a1 axis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1050093
|
| 9 |
Jian Song, Zhen-Yu Cui, Li-Hua Lian, Xin Han, Li-Shuang Hou, Ge Wang, Lu Gao, Yue Zhu, Yu-Chen Jiang, Jia-Yi Dou, Zhong-He Hu, Yu-Qing Zhao, Ji-Xing Nan, Yan-Ling Wu. 20S-Protopanaxatriol Ameliorates Hepatic Fibrosis, Potentially Involving FXR-Mediated Inflammatory Signaling Cascades. Journal of Agricultural and Food Chemistry 2020; 68(31): 8195 doi: 10.1021/acs.jafc.0c01978
|
| 10 |
Hye Jin Lee, Bianca R. Tomasini-Johansson, Nikesh Gupta, Glen S. Kwon. Fibronectin-targeted FUD and PEGylated FUD peptides for fibrotic diseases. Journal of Controlled Release 2023; 360: 69 doi: 10.1016/j.jconrel.2023.06.008
|
| 11 |
Antonio Sircana, Elena Paschetta, Francesca Saba, Federica Molinaro, Giovanni Musso. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. International Journal of Molecular Sciences 2019; 20(7): 1745 doi: 10.3390/ijms20071745
|
| 12 |
Maha G. Elfeky, Eman M. Mantawy, Amany M. Gad, Hala M. Fawzy, Ebtehal El-Demerdash. Mechanistic aspects of antifibrotic effects of honokiol in Con A-induced liver fibrosis in rats: Emphasis on TGF-β/SMAD/MAPK signaling pathways. Life Sciences 2020; 240: 117096 doi: 10.1016/j.lfs.2019.117096
|
| 13 |
Dandan Zheng, Yuchuan Jiang, Chen Qu, Hui Yuan, Kaishun Hu, Lu He, Peng Chen, Jinying Li, Mengxian Tu, Lehang Lin, Hengxing Chen, Zelong Lin, Wenyu Lin, Jun Fan, Guohua Cheng, Jian Hong. Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis. The American Journal of Pathology 2020; 190(11): 2267 doi: 10.1016/j.ajpath.2020.08.002
|
| 14 |
Nan Wei, Lizhou Wang, Min Xu, Tianzhi An, Xueqing Huang, Shi Zhou. Research on mechanism of tanshinone a in regulating biological characteristics of hematopoietic stem cell in liver cirrhosis through targeting of miR-9a-5p. Materials Express 2022; 12(5): 653 doi: 10.1166/mex.2022.2194
|
| 15 |
Chelsea Chandler, Tianshi Liu, Ronald Buckanovich, Lan G. Coffman. The double edge sword of fibrosis in cancer. Translational Research 2019; 209: 55 doi: 10.1016/j.trsl.2019.02.006
|
| 16 |
Qian-Qian Fan, Cheng-Lu Zhang, Jian-Bin Qiao, Peng-Fei Cui, Lei Xing, Yu-Kyoung Oh, Hu-Lin Jiang. Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy. Biomaterials 2020; 230: 119616 doi: 10.1016/j.biomaterials.2019.119616
|
| 17 |
Li-Ping CHEN, Xiao-Qian WU, Zi-Li ZHANG, Ling WANG, Feng ZHANG, Shi-Zhong ZHENG, De-Song KONG. Evaluate the effect of licorice on anti-liver fibrosis: a systematic review and meta-analysis. Food Science and Technology 2022; 42 doi: 10.1590/fst.103321
|
| 18 |
Kristina Duspara, Kristina Bojanic, Josipa Ivanusic Pejic, Lucija Kuna, Tea Omanovic Kolaric, Vjera Nincevic, Robert Smolic, Aleksandar Vcev, Marija Glasnovic, Ines Bilic Curcic, Martina Smolic. Targeting the Wnt Signaling Pathway in Liver Fibrosis for Drug Options: An Update. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00065
|
| 19 |
Chunhua Wan, Tianye Gu, Junyi Ling, Yi Qin, Jiashan Luo, Lingli Sun, Lu Hua, Jianya Zhao, Shengyang Jiang. Perfluorooctane sulfonate aggravates CCl4‐induced hepatic fibrosis via HMGB1/TLR4/Smad signaling. Environmental Toxicology 2022; 37(5): 983 doi: 10.1002/tox.23458
|
| 20 |
Takayuki Miyoshi, Masaaki Hidaka, Daisuke Miyamoto, Yusuke Sakai, Shunsuke Murakami, Yu Huang, Takanobu Hara, Akihiko Soyama, Kengo Kanetaka, Takahiro Ochiya, Susumu Eguchi. Successful induction of human chemically induced liver progenitors with small molecules from damaged liver. Journal of Gastroenterology 2022; 57(6): 441 doi: 10.1007/s00535-022-01869-5
|
| 21 |
Niklas Handin, Di Yuan, Magnus Ölander, Christine Wegler, Cecilia Karlsson, Rasmus Jansson-Löfmark, Jøran Hjelmesæth, Anders Åsberg, Volker M. Lauschke, Per Artursson. Proteome deconvolution of liver biopsies reveals hepatic cell composition as an important marker of fibrosis. Computational and Structural Biotechnology Journal 2023; 21: 4361 doi: 10.1016/j.csbj.2023.08.037
|
| 22 |
Bárbara González-Fernández, Diana I. Sánchez, Javier González-Gallego, María J. Tuñón. Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00579
|
| 23 |
Joanna Maria Lotowska, Maria Elzbieta Sobaniec-Lotowska, Dariusz Marek Lebensztejn. Ultrastructural characteristics of the respective forms of hepatic stellate cells in chronic hepatitis B as an example of high fibroblastic cell plasticity. The first assessment in children. Advances in Medical Sciences 2018; 63(1): 127 doi: 10.1016/j.advms.2017.09.002
|
| 24 |
María Isabel Hernández-Alvarez, Antonio Zorzano. Mitochondrial Dynamics and Liver Cancer. Cancers 2021; 13(11): 2571 doi: 10.3390/cancers13112571
|
| 25 |
U Rajendra Acharya, U Raghavendra, Joel E W Koh, Kristen M Meiburger, Edward J Ciaccio, Yuki Hagiwara, Filippo Molinari, Wai Ling Leong, Anushya Vijayananthan, Nur Adura Yaakup, Mohd Kamil Bin Mohd Fabell, Chai Hong Yeong. Automated detection and classification of liver fibrosis stages using contourlet transform and nonlinear features. Computer Methods and Programs in Biomedicine 2018; 166: 91 doi: 10.1016/j.cmpb.2018.10.006
|
| 26 |
Adnan Naim, Mirza S. Baig. Matrix metalloproteinase-8 (MMP-8) regulates the activation of hepatic stellate cells (HSCs) through the ERK-mediated pathway. Molecular and Cellular Biochemistry 2020; 467(1-2): 107 doi: 10.1007/s11010-020-03705-x
|
| 27 |
Yuan Hu, Xiaoling Wang, Yuhuan Wei, Hua Liu, Jing Zhang, Yujuan Shen, Jianping Cao. Functional Inhibition of Natural Killer Cells in a BALB/c Mouse Model of Liver Fibrosis Induced by Schistosoma japonicum Infection. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.598987
|
| 28 |
Mengying Hu, Leaf Huang. Nanomaterial Manipulation of Immune Microenvironment in the Diseased Liver. Advanced Functional Materials 2019; 29(7) doi: 10.1002/adfm.201805760
|
| 29 |
Qianyuan Gong, Zhaoyu Zeng, Tao Jiang, Xue Bai, Chunlan Pu, Yaying Hao, Yuanbiao Guo. Anti-fibrotic effect of extracellular vesicles derived from tea leaves in hepatic stellate cells and liver fibrosis mice. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1009139
|
| 30 |
Rehab S. Abdelrahman, Ghada S. El-Tanbouly. Protocatechuic acid protects against thioacetamide-induced chronic liver injury and encephalopathy in mice via modulating mTOR, p53 and the IL-6/ IL-17/ IL-23 immunoinflammatory pathway. Toxicology and Applied Pharmacology 2022; 440: 115931 doi: 10.1016/j.taap.2022.115931
|
| 31 |
Yabing Guo, Geng Tian, Xin Chen, Yingjian Hou, Xinyu Zhang, Xin Xue, Li Zhao, Yun Wu. GL-V9 ameliorates liver fibrosis by inhibiting TGF-β/smad pathway. Experimental Cell Research 2023; 425(1): 113521 doi: 10.1016/j.yexcr.2023.113521
|
| 32 |
Tomohisa Yoneyama, Takehisa Ueno, Kazunori Masahata, Chiyoshi Toyama, Akira Maeda, Yuko Tazuke, Takaharu Oue, Shuji Miyagawa, Hiroomi Okuyama. Elevation of microRNA-214 is associated with progression of liver fibrosis in patients with biliary atresia. Pediatric Surgery International 2022; 38(1): 115 doi: 10.1007/s00383-021-05009-7
|
| 33 |
Congping Ying, Xin Fang, Honglan Wang, Yanping Yang, Pao Xu, Kai Liu, Guojun Yin. Anisakidae parasitism activated immune response and induced liver fibrosis in wild anadromous Coilia nasus. Journal of Fish Biology 2022; 100(4): 958 doi: 10.1111/jfb.15027
|
| 34 |
Maria Jimenez Ramos, Lucia Bandiera, Filippo Menolascina, Jonathan Andrew Fallowfield. In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applications. iScience 2022; 25(1): 103549 doi: 10.1016/j.isci.2021.103549
|
| 35 |
A. Yu. Filippova. Diagnostics of progression of liver fibrosis in patients with non-alcoholic steatohepatitis combined with obesity and chronic calculous cholecystitis.. Medicni perspektivi (Medical perspectives) 2020; 25(1): 65 doi: 10.26641/2307-0404.2020.1.200403
|
| 36 |
Erika Ramos-Tovar, Rosa E. Flores-Beltrán, Silvia Galindo-Gómez, Javier Camacho, Víctor Tsutsumi, Pablo Muriel. An aqueous extract of Stevia rebaudiana variety Morita II prevents liver damage in a rat model of cirrhosis that mimics the human disease. Annals of Hepatology 2019; 18(3): 472 doi: 10.1016/j.aohep.2018.10.002
|
| 37 |
Qin Yu, Xiaoqin Xiong, Lei Zhao, Tingting Xu, Qianhua Wang. Antifibrotic effects of specific siRNA targeting connective tissue growth factor delivered by polyethyleneimine‑functionalized magnetic iron oxide nanoparticles on LX‑2 cells. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10834
|
| 38 |
Daolin Xie, Minghua Ying, Jingru Lian, Xin Li, Fangyi Liu, Xiaoling Yu, Caifang Ni. Serological indices and ultrasound variables in predicting the staging of hepatitis B liver fibrosis: A comparative study based on random forest algorithm and traditional methods. Journal of Cancer Research and Therapeutics 2022; 18(7): 2049 doi: 10.4103/jcrt.jcrt_1394_22
|
| 39 |
Hyun-Ju Park, Juyoung Choi, Hyunmi Kim, Da-Yeon Yang, Tae Hyeon An, Eun-Woo Lee, Baek-Soo Han, Sang Chul Lee, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Cellular heterogeneity and plasticity during NAFLD progression. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1221669
|
| 40 |
Avnish Verma, Jason Bennett, Ayşe Merve Örme, Elena Polycarpou, Brian Rooney. Cocaine addicted to cytoskeletal change and a fibrosis high. Cytoskeleton 2019; 76(2): 177 doi: 10.1002/cm.21510
|
| 41 |
Jin Ha Lee, Ji Young Oh, Soo Hyun Kim, In Jeong Oh, Yong-ho Lee, Keun Woo Lee, Woong Hee Lee, Jeong-Hwan Kim. Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH). Biomolecules 2020; 10(10): 1426 doi: 10.3390/biom10101426
|
| 42 |
Joseph George, Mutsumi Tsuchishima, Mikihiro Tsutsumi. Epigallocatechin-3-gallate inhibits osteopontin expression and prevents experimentally induced hepatic fibrosis. Biomedicine & Pharmacotherapy 2022; 151: 113111 doi: 10.1016/j.biopha.2022.113111
|
| 43 |
Mengna Wu, Huajie Miao, Rong Fu, Jie Zhang, Wenjie Zheng . Hepatic Stellate Cell: A Potential Target for Hepatocellular Carcinoma. Current Molecular Pharmacology 2020; 13(4): 261 doi: 10.2174/1874467213666200224102820
|
| 44 |
Yuan Zhang, Wenjun Lu, Xiaorong Chen, Yajuan Cao, Zongguo Yang, Udayan Apte. A Bioinformatic Analysis of Correlations between Polymeric Immunoglobulin Receptor (PIGR) and Liver Fibrosis Progression. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/5541780
|
| 45 |
Yuchen Ma, Yanni Bao, Lifang Wu, Yijun Ke, Lina Tan, Huan Ren, Jue Song, Qian Zhang, Yong Jin. IL-8 exacerbates CCl4-induced liver fibrosis in human IL-8-expressing mice via the PI3K/Akt/HIF-1α pathway. Molecular Immunology 2022; 152: 111 doi: 10.1016/j.molimm.2022.10.011
|
| 46 |
Wenlong Hao, Minghao Li, Qingmin Cai, Shiying Wu, Xiangyao Li, Quanyu He, Yongbin Hu. Roles of NRF2 in Fibrotic Diseases: From Mechanisms to Therapeutic Approaches. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.889792
|
| 47 |
Reinier J. de Vries, Casie A. Pendexter, Stephanie E. J. Cronin, Beatriz Marques, Ehab O. A. Hafiz, Alona Muzikansky, Thomas M. van Gulik, James F. Markmann, Shannon L. Stott, Heidi Yeh, Mehmet Toner, Korkut Uygun, Shannon N. Tessier. Cell release during perfusion reflects cold ischemic injury in rat livers. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-57589-4
|
| 48 |
Liang-Mou Kuo, Po-Jen Chen, Ping-Jyun Sung, Yu-Chia Chang, Chun-Ting Ho, Yi-Hsiu Wu, Tsong-Long Hwang. The Bioactive Extract of Pinnigorgia sp. Induces Apoptosis of Hepatic Stellate Cells via ROS-ERK/JNK-Caspase-3 Signaling. Marine Drugs 2018; 16(1): 19 doi: 10.3390/md16010019
|
| 49 |
Jaiwoo Lee, Junho Byun, Gayong Shim, Yu-Kyoung Oh. Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis. Nature Communications 2022; 13(1) doi: 10.1038/s41467-022-29186-8
|
| 50 |
Wen-Qing Li, Wen-Hao Liu, Die Qian, Jia Liu, Shi-Qiong Zhou, Lei Zhang, Wei Peng, Li Su, Hong Zhang. Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.962525
|
| 51 |
Cornel Balta, Hildegard Herman, Alina Ciceu, Bianca Mladin, Marcel Rosu, Alciona Sasu, Victor Eduard Peteu, Sorina Nicoleta Voicu, Mihaela Balas, Mihaela Gherghiceanu, Anca Dinischiotu, Neli Kinga Olah, Anca Hermenean. Phytochemical Profiling and Anti-Fibrotic Activities of the Gemmotherapy Bud Extract of Corylus avellana in a Model of Liver Fibrosis on Diabetic Mice. Biomedicines 2023; 11(6): 1771 doi: 10.3390/biomedicines11061771
|
| 52 |
Lin Xu, Chenyan Yang, Jie Ma, Xinge Zhang, Qingzhi Wang, Xiwen Xiong. NAMPT-mediated NAD+ biosynthesis suppresses activation of hepatic stellate cells and protects against CCl4-induced liver fibrosis in mice. Human & Experimental Toxicology 2021; 40(12_suppl): S666 doi: 10.1177/09603271211052991
|
| 53 |
Shengwang Wu, Laicheng Liu, Sen Yang, Ge Kuang, Xinru Yin, Yuanyuan Wang, Fangzhi Xu, Lingyi Xiong, Meixia Zhang, Jingyuan Wan, Xia Gong. Paeonol alleviates CCl4-induced liver fibrosis through suppression of hepatic stellate cells activation via inhibiting the TGF-β/Smad3 signaling. Immunopharmacology and Immunotoxicology 2019; 41(3): 438 doi: 10.1080/08923973.2019.1613427
|
| 54 |
Fei Yin, Wen-Ying Wang, Wen-Hua Jiang. Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis <i>in vitro</i> and <i>in vivo</i>: From biological characteristics to therapeutic mechanisms. World Journal of Stem Cells 2019; 11(8): 548-564 doi: 10.4252/wjsc.v11.i8.548
|
| 55 |
Sihang Yu, Lei Zhou, Jiaying Fu, Long Xu, Buhan Liu, Yuanxin Zhao, Jian Wang, Xiaoyu Yan, Jing Su. H-TEX-mediated signaling between hepatocellular carcinoma cells and macrophages and exosome-targeted therapy for hepatocellular carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.997726
|
| 56 |
Huaqing Jing, Yingzi Ren, Yue Zhou, Min Xu, Sona Krizkova, Zbynek Heger, Qiang Lu, Siyu Wang, Xiaoyang Liang, Vojtech Adam, Nan Li. Remodeling of the liver fibrosis microenvironment based on nilotinib-loaded multicatalytic nanozymes with boosted antifibrogenic activity. Acta Pharmaceutica Sinica B 2023; 13(12): 5030 doi: 10.1016/j.apsb.2023.08.020
|
| 57 |
Fei Huang, Guanxin Ding, Yanjie Yuan, Lijun Zhao, Wenmeng Ding, Shunhua Wu. PTEN Overexpression Alters Autophagy Levels and Slows Sodium Arsenite-Induced Hepatic Stellate Cell Fibrosis. Toxics 2023; 11(7): 578 doi: 10.3390/toxics11070578
|
| 58 |
Li Chen, Desong Kong, Siwei Xia, Feixia Wang, Zhanghao Li, Feng Zhang, Shizhong Zheng. Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.891069
|
| 59 |
Berna Karakoyun. Liver Cirrhosis - Update and Current Challenges. 2017; doi: 10.5772/intechopen.68641
|
| 60 |
Yuting Chen, Zhiyong Liang, Maode Lai. Targeting the Devil: Strategies Against Cancer-Associated Fibroblasts in Colorectal Cancer. Translational Research 2024; doi: 10.1016/j.trsl.2024.04.003
|
| 61 |
Shovik S. Patel, Amitha Sandur, Mohammed El-Kebir, Ron C. Gaba, Lawrence B. Schook, Kyle M. Schachtschneider. Transcriptional Profiling of Porcine HCC Xenografts Provides Insights Into Tumor Cell Microenvironment Signaling. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.657330
|
| 62 |
Li-Shuang Hou, Yao-Wen Zhang, Hua Li, Wei Wang, Meng-Lei Huan, Si-Yuan Zhou, Bang-Le Zhang. The regulatory role and mechanism of autophagy in energy metabolism-related hepatic fibrosis. Pharmacology & Therapeutics 2022; 234: 108117 doi: 10.1016/j.pharmthera.2022.108117
|
| 63 |
Betul Gok Yavuz, Roberto Carmagnani Pestana, Yehia I. Abugabal, Sunil Krishnan, Jian Chen, Manal M. Hassan, Robert A. Wolff, Asif Rashid, Hesham M. Amin, Ahmed O. Kaseb. Origin and role of hepatic myofibroblasts in hepatocellular carcinoma. Oncotarget 2020; 11(13): 1186 doi: 10.18632/oncotarget.27532
|
| 64 |
Xingqi Wang, Yuzhi Gao, Yu Li, Yuqing Huang, Yawen Zhu, Wei lv, Ruzeng Wang, Lingshan Gou, Chao Cheng, Zhaojun Feng, Jun Xie, Jun Tian, Ruiqin Yao. Roseotoxin B alleviates cholestatic liver fibrosis through inhibiting PDGF-B/PDGFR-β pathway in hepatic stellate cells. Cell Death & Disease 2020; 11(6) doi: 10.1038/s41419-020-2575-0
|
| 65 |
Umesh K. Goand, Inklisan Patel, Saurabh Verma, Shubhi Yadav, Debalina Maity, Naveen Singh, Sachin Vishwakarma, Shivam Rathaur, Richa Garg, Jiaur R. Gayen. Immunometabolic impact of pancreastatin inhibitor PSTi8 in MCD induced mouse model of oxidative stress and steatohepatitis. Cytokine 2023; 171: 156354 doi: 10.1016/j.cyto.2023.156354
|
| 66 |
Raja Gopal Reddy Mooli, Dhanunjay Mukhi, Sadeesh K. Ramakrishnan. Comprehensive Physiology. 2022; : 3167 doi: 10.1002/cphy.c200021
|
| 67 |
Erika Ramos‐Tovar, Rosa E. Flores‐Beltrán, Silvia Galindo‐Gómez, Eunice Vera‐Aguilar, Araceli Diaz‐Ruiz, Sergio Montes, Javier Camacho, Víctor Tsutsumi, Pablo Muriel. Stevia rebaudiana tea prevents experimental cirrhosis via regulation of NF‐κB, Nrf2, transforming growth factor beta, Smad7, and hepatic stellate cell activation. Phytotherapy Research 2018; 32(12): 2568 doi: 10.1002/ptr.6197
|
| 68 |
Xinrui Xing, Si Chen, Ling Li, Yan Cao, Langdong Chen, Xiaobo Wang, Zhenyu Zhu. The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability – A Network Pharmacology and Transcriptomics Approach. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00525
|
| 69 |
Yong-Joo Park, Dong-Min Kim, Hye-Been Choi, Mi-Ho Jeong, Seung-Hwan Kwon, Ha-Ryong Kim, Jong-Hwan Kwak, Kyu-Hyuck Chung. Dendropanoxide, a Triterpenoid from Dendropanax morbifera, Ameliorates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells through Autophagy Inhibition. Nutrients 2021; 14(1): 98 doi: 10.3390/nu14010098
|
| 70 |
Fang Hu, Xingcheng Zhou, Qianqian Peng, Lu Ma. Suppressed Histone H3 Lysine 18 Acetylation Is Involved in Arsenic-Induced Liver Fibrosis in Rats by Triggering the Dedifferentiation of Liver Sinusoidal Endothelial Cells. Toxics 2023; 11(11): 928 doi: 10.3390/toxics11110928
|
| 71 |
Jie Liang, Hongwei Yuan, Liping Xu, Feng Wang, Xiaomei Bao, Yuxin Yan, Haisheng Wang, Chunyan Zhang, Rong Jin, Lijie Ma, Jianyu Zhang, Lebagen Huri, Xiaoli Su, Rui Xiao, Yuehong Ma. Study on the effect of Mongolian medicine Qiwei Qinggan Powder on hepatic fibrosis through JAK2/STAT3 pathway. Bioscience, Biotechnology, and Biochemistry 2021; 85(4): 775 doi: 10.1093/bbb/zbab001
|
| 72 |
Serena Del Turco, Paolo De Simone, Davide Ghinolfi, Melania Gaggini, Giuseppina Basta. Comparison between galectin-3 and YKL-40 levels for the assessment of liver fibrosis in cirrhotic patients. Arab Journal of Gastroenterology 2021; 22(3): 187 doi: 10.1016/j.ajg.2021.03.002
|
| 73 |
José Roberto Macías-Pérez, Bruno Jesús Vázquez-López, Martin Humberto Muñoz-Ortega, Liseth Rubí Aldaba-Muruato, Sandra Luz Martínez-Hernández, Esperanza Sánchez-Alemán, Javier Ventura-Juárez. Curcumin and α/β-Adrenergic Antagonists Cotreatment Reverse Liver Cirrhosis in Hamsters: Participation of Nrf-2 and NF-κB. Journal of Immunology Research 2019; 2019: 1 doi: 10.1155/2019/3019794
|
| 74 |
Helia Alavifard, Sogol Mazhari, Anna Meyfour, Samaneh Tokhanbigli, Saeid Ghavami, Mohammad Reza Zali, Hamid Asadzadeh Aghdaei, Behzad Hatami, Kaveh Baghaei. Imatinib suppresses activation of hepatic stellate cells by targeting STAT3/IL‐6 pathway through miR‐124. Cell Biology International 2023; 47(5): 969 doi: 10.1002/cbin.11992
|
| 75 |
Joanna Maria Łotowska, Maria Elżbieta Sobaniec-Łotowska, Anna Bobrus-Chociej, Piotr Sobaniec. The Ultrastructure of Hepatic Stellate Cell–Macrophage Intercellular Crosstalk as a New Morphological Insight into Phenomenon of Fibrogenesis in Pediatric Autoimmune Hepatitis. Journal of Clinical Medicine 2023; 12(3): 1024 doi: 10.3390/jcm12031024
|
| 76 |
Felix Hempel, Martin Roderfeld, Rajkumar Savai, Akylbek Sydykov, Karuna Irungbam, Ralph Schermuly, Robert Voswinckel, Kernt Köhler, Yury Churin, Ladislau Kiss, Jens Bier, Jörn Pons-Kühnemann, Elke Roeb. Depletion of Bone Marrow-Derived Fibrocytes Attenuates TAA-Induced Liver Fibrosis in Mice. Cells 2019; 8(10): 1210 doi: 10.3390/cells8101210
|
| 77 |
Ana S. Serras, Joana S. Rodrigues, Madalena Cipriano, Armanda V. Rodrigues, Nuno G. Oliveira, Joana P. Miranda. A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.626805
|
| 78 |
Lichun Ma, Subreen Khatib, Amanda J. Craig, Xin Wei Wang. Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution. Seminars in Liver Disease 2021; 41(03): 321 doi: 10.1055/s-0041-1729970
|
| 79 |
Mi-Rae Shin, Jin A Lee, Minju Kim, Sehui Lee, Minhyuck Oh, Jimin Moon, Joo-Won Nam, Hyukjae Choi, Yeun-Ja Mun, Seong-Soo Roh. Gardeniae Fructus Attenuates Thioacetamide-Induced Liver Fibrosis in Mice via Both AMPK/SIRT1/NF-κB Pathway and Nrf2 Signaling. Antioxidants 2021; 10(11): 1837 doi: 10.3390/antiox10111837
|
| 80 |
Tingting Qiu, Jinge Yang, Chihan Peng, Hongjin Xiang, Lin Huang, Wenwu Ling, Yan Luo. Diagnosis of liver fibrosis and liver function reserve through non-invasive multispectral photoacoustic imaging. Photoacoustics 2023; 33: 100562 doi: 10.1016/j.pacs.2023.100562
|
| 81 |
Marina Fuertes-Agudo, María Luque-Tévar, Carme Cucarella, Paloma Martín-Sanz, Marta Casado. Advances in Understanding the Role of NRF2 in Liver Pathophysiology and Its Relationship with Hepatic-Specific Cyclooxygenase-2 Expression. Antioxidants 2023; 12(8): 1491 doi: 10.3390/antiox12081491
|
| 82 |
Liming Liu, Ying Zhou, Dan Dai, Hongmei Xia, Kang Zhao, Jianjun Zhang, Samuel Martins Silvestre. Antifibrotic Effects of Kangxian Ruangan Capsule on Rats with Nonalcoholic Fatty Liver Fibrosis and Hepatic Stellate Cells through Regulation of TGF-β and TLR4 Signaling Pathways. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5649575
|
| 83 |
Zhifa Wang, Xiaoke Yang, Siyu Gui, Fan Yang, Zhuo Cao, Rong Cheng, Xiaowei Xia, Chuanying Li. The Roles and Mechanisms of lncRNAs in Liver Fibrosis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.779606
|
| 84 |
Haoyuan Peng, Lei Zhong, Lin Cheng, Lu Chen, Rongsheng Tong, Jianyou Shi, Lan Bai. Ganoderma lucidum: Current advancements of characteristic components and experimental progress in anti-liver fibrosis. Frontiers in Pharmacology 2023; 13 doi: 10.3389/fphar.2022.1094405
|
| 85 |
Youxiang Zhang, De-Hui Xiong, Yangyang Li, Guina Xu, Baoxin Zhang, Yang Liu, Shan Zhang, Qing Huang, Simin Chen, Fansheng Zeng, Jingyi Guo, Bin Li, Zhiqiang Qin, Zuping Zhang, Luiz Felipe Domingues Passero. Schistosoma japonicum Infection in Treg-Specific USP21 Knockout Mice. Journal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/6613162
|
| 86 |
Yutong Dong, Yuwei Liu, Xu Liu, Heming Ma, Yahui Liu, Guoyue Lv, Junqi Niu. Multi‐omics profiling of primary hepatic stellate cells from advanced liver fibrosis patients reveals distinctive molecular signatures. Journal of Gastroenterology and Hepatology 2023; 38(8): 1416 doi: 10.1111/jgh.16221
|
| 87 |
Yuan-Yuan Wu, Sha Wu, Xiao-Feng Li, Shuai Luo, Ao Wang, Su-Qin Yin, Cheng Huang, Jun Li. LncRNA MEG3 reverses CCl4-induced liver fibrosis by targeting NLRC5. European Journal of Pharmacology 2021; 911: 174462 doi: 10.1016/j.ejphar.2021.174462
|
| 88 |
Yula Kaminsky-Kolesnikov, Einat Rauchbach, Diana Abu-Halaka, Michal Hahn, Carmen García-Ruiz, Jose C. Fernandez-Checa, Zecharia Madar, Oren Tirosh. Cholesterol Induces Nrf-2- and HIF-1α-Dependent Hepatocyte Proliferation and Liver Regeneration to Ameliorate Bile Acid Toxicity in Mouse Models of NASH and Fibrosis. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/5393761
|
| 89 |
Nermin A. Ali, Nadia M. Hamdy, Abdullah A. Gibriel, Hala O. EL Mesallamy. Investigation of the relationship between CTLA4 and the tumor suppressor RASSF1A and the possible mediating role of STAT4 in a cohort of Egyptian patients infected with hepatitis C virus with and without hepatocellular carcinoma. Archives of Virology 2021; 166(6): 1643 doi: 10.1007/s00705-021-04981-8
|
| 90 |
Heather E. Talbott, Shamik Mascharak, Michelle Griffin, Derrick C. Wan, Michael T. Longaker. Wound healing, fibroblast heterogeneity, and fibrosis. Cell Stem Cell 2022; 29(8): 1161 doi: 10.1016/j.stem.2022.07.006
|
| 91 |
Yan Lin, Yaqiong Lu, Xun Li. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents. Journal of Drug Targeting 2020; 28(2): 129 doi: 10.1080/1061186X.2019.1641508
|
| 92 |
Li Ma, Junfeng Wei, Yanli Zeng, Junping Liu, Erhui Xiao, Yuehua Kang, Yi Kang. Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis. Drug Delivery 2022; 29(1): 440 doi: 10.1080/10717544.2022.2030428
|
| 93 |
Yang Tian, Yongfei Li, Wen-Xin Wang, Wen-Li Jiang, Junjie Fei, Chun-Yan Li. Novel Strategy for Validating the Existence and Mechanism of the “Gut–Liver Axis” in Vivo by a Hypoxia-Sensitive NIR Fluorescent Probe. Analytical Chemistry 2020; 92(6): 4244 doi: 10.1021/acs.analchem.9b04578
|
| 94 |
Li-shuang Hou, Yao-Wen Zhang, Hua Li, Wei Wang, Meng-Lei Huan, Si-Yuan Zhou, Bang-Le Zhang. The Regulatory Role and Mechanism of Autophagy in Energy Metabolism-Related Hepatic Fibrosis. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3976044
|
| 95 |
Ming-ming Ni, Ya-rui Wang, Wen-wen Wu, Chong-cai Xia, Yi-he Zhang, Jing Xu, Tao Xu, Jun Li. Novel Insights on Notch signaling pathways in liver fibrosis. European Journal of Pharmacology 2018; 826: 66 doi: 10.1016/j.ejphar.2018.02.051
|
| 96 |
Dong-Jing Yang, Ji-Hua Shi, Zong-Ping Xia, Wen-Zhi Guo, Mohammed Shakil Ahmed, Shui-Jun Zhang. Hepatic connective tissue growth factor expression and regulation differ between non-steatotic and non-alcoholic steatotic livers from brain-dead donor. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83516-2
|
| 97 |
Baocai Wang, Benedikt Kaufmann, Carolin Mogler, Suyang Zhong, Yuhan Yin, Zhangjun Cheng, Roland M. Schmid, Helmut Friess, Norbert Hüser, Guido von Figura, Daniel Hartmann, Sudhir Kumar Rai. Hepatocellular Brg1 promotes CCl4-induced liver inflammation, ECM accumulation and fibrosis in mice. PLOS ONE 2023; 18(11): e0294257 doi: 10.1371/journal.pone.0294257
|
| 98 |
Myungsuk Kim, GyHye Yoo, Ahmad Randy, Yang-Ju Son, Chi Rac Hong, Sang Min Kim, Chu Won Nho. Lemon Balm and Its Constituent, Rosmarinic Acid, Alleviate Liver Damage in an Animal Model of Nonalcoholic Steatohepatitis. Nutrients 2020; 12(4): 1166 doi: 10.3390/nu12041166
|
| 99 |
Chen Wang, Jinwen Liu, Yongmin Yan, Youwen Tan, Liu Jinhui. Role of Exosomes in Chronic Liver Disease Development and Their Potential Clinical Applications. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/1695802
|
| 100 |
Xia Niu, Yanan Meng, Jinjin Cui, Rui Li, Xiao Ding, Bingyu Niu, Ge Chang, Ning Xu, Guiling Li, Yucheng Wang, Lulu Wang. Hepatic Stellate Cell- and Liver Microbiome-Specific Delivery System for Dihydrotanshinone I to Ameliorate Liver Fibrosis. ACS Nano 2023; 17(23): 23608 doi: 10.1021/acsnano.3c06626
|
| 101 |
Yingying Lu, Qin M Chen, Lingling An. Semi-reference based cell type deconvolution with application to human metastatic cancers. NAR Genomics and Bioinformatics 2023; 5(4) doi: 10.1093/nargab/lqad109
|
| 102 |
Qian-Yang Zhou, Hui-Min Yang, Ji-Xin Liu, Na Xu, Jing Li, Li-Ping Shen, Yu-Zhao Zhang, Stephane Koda, Bei-Bei Zhang, Qian Yu, Jia-Xu Chen, Kui-Yang Zheng, Chao Yan. MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-β/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7. Parasites & Vectors 2021; 14(1) doi: 10.1186/s13071-021-04972-3
|
| 103 |
Vidyasagar Naik Bukke, Archana Moola, Gaetano Serviddio, Gianluigi Vendemiale, Francesco Bellanti. Nuclear factor erythroid 2-related factor 2-mediated signaling and metabolic associated fatty liver disease. World Journal of Gastroenterology 2022; 28(48): 6909-6921 doi: 10.3748/wjg.v28.i48.6909
|
| 104 |
Yan Wang, Xiong Xiao, Xiaobo Wang, Feng Guo, Xiaozhong Wang, Amit Kumar Pandey. Identification of differentially expressed long noncoding RNAs and pathways in liver tissues from rats with hepatic fibrosis. PLOS ONE 2021; 16(10): e0258194 doi: 10.1371/journal.pone.0258194
|
| 105 |
Lijuan Dan, Yanwei Hao, Hongfei Song, Tianyuan Wang, Jia Li, Xiaoyan He, Yue Su. Efficacy and potential mechanisms of the main active ingredients of astragalus mongholicus in animal models of liver fibrosis: A systematic review and meta-analysis. Journal of Ethnopharmacology 2024; 319: 117198 doi: 10.1016/j.jep.2023.117198
|
| 106 |
Xu Liu, Heming Ma, Ruihong Wu, Huan Wang, Hongqin Xu, Shuxuan Li, Guangyi Wang, Guoyue Lv, Junqi Niu. Identification of Liver Fibrosis-Related MicroRNAs in Human Primary Hepatic Stellate Cells Using High-Throughput Sequencing. Genes 2022; 13(12): 2201 doi: 10.3390/genes13122201
|
| 107 |
Giovanna Trinchese, Patrizia Gena, Fabiano Cimmino, Gina Cavaliere, Chiara Fogliano, Sabino Garra, Angela Catapano, Lidia Petrella, Silvia Di Chio, Bice Avallone, Giuseppe Calamita, Maria Pina Mollica. Hepatocyte Aquaporins AQP8 and AQP9 Are Engaged in the Hepatic Lipid and Glucose Metabolism Modulating the Inflammatory and Redox State in Milk-Supplemented Rats. Nutrients 2023; 15(16): 3651 doi: 10.3390/nu15163651
|
| 108 |
Ping Song, Juan‐Li Duan, Jian Ding, Jing‐Jing Liu, Zhi‐Qiang Fang, Hao Xu, Zhi‐Wen Li, Wei Du, Ming Xu, Yu‐Wei Ling, Fei He, Kai‐Shan Tao, Lin Wang. Cellular senescence primes liver fibrosis regression through Notch‐EZH2. MedComm 2023; 4(5) doi: 10.1002/mco2.346
|
| 109 |
Dong-Dong Wu, Da-Yong Wang, Hui-Min Li, Jian-Cheng Guo, Shao-Feng Duan, Xin-Ying Ji. Hydrogen Sulfide as a Novel Regulatory Factor in Liver Health and Disease. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/3831713
|
| 110 |
Maryam Melaibari, Huda M. Alkreathy, Ahmed Esmat, Nisreen A. Rajeh, Rasheed A. Shaik, Anwar A. Alghamdi, Aftab Ahmad. Anti-Fibrotic Efficacy of Apigenin in a Mice Model of Carbon Tetrachloride-Induced Hepatic Fibrosis by Modulation of Oxidative Stress, Inflammation, and Fibrogenesis: A Preclinical Study. Biomedicines 2023; 11(5): 1342 doi: 10.3390/biomedicines11051342
|
| 111 |
Nicolás Salva-Pastor, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease. The Journal of Steroid Biochemistry and Molecular Biology 2019; 194: 105445 doi: 10.1016/j.jsbmb.2019.105445
|
| 112 |
Zhi Wang, Kailei Du, Nake Jin, Biao Tang, Wenwu Zhang. Macrophage in liver Fibrosis: Identities and mechanisms. International Immunopharmacology 2023; 120: 110357 doi: 10.1016/j.intimp.2023.110357
|
| 113 |
Qingjie Fu, Shunsuke Ohnishi, Naoya Sakamoto. Conditioned Medium from Human Amnion-Derived Mesenchymal Stem Cells Regulates Activation of Primary Hepatic Stellate Cells. Stem Cells International 2018; 2018: 1 doi: 10.1155/2018/4898152
|
| 114 |
Antonella Mosca, Nadia Panera, Annalisa Crudele, Anna Alisi. Noninvasive diagnostic tools for pediatric NAFLD: where are we now?. Expert Review of Gastroenterology & Hepatology 2020; 14(11): 1035 doi: 10.1080/17474124.2020.1801413
|
| 115 |
Xu Gong, Linlin Shan, Sisi Cao, Kaitao Li, Yanli Wu, Qing Zhang. Notoginsenoside R1, An Active Compound from Panax notoginseng, Inhibits Hepatic Stellate Cell Activation and Liver Fibrosis via MAPK Signaling Pathway. The American Journal of Chinese Medicine 2022; 50(02): 511 doi: 10.1142/S0192415X22500197
|
| 116 |
Nidhi Sharma, Taslim B. Shaikh, Abhisheik Eedara, Madhusudhana Kuncha, Ramakrishna Sistla, Sai Balaji Andugulapati. Dehydrozingerone ameliorates thioacetamide-induced liver fibrosis via inhibition of hepatic stellate cells activation through modulation of the MAPK pathway. European Journal of Pharmacology 2022; 937: 175366 doi: 10.1016/j.ejphar.2022.175366
|
| 117 |
Leona Radmanić, Snježana Zidovec-Lepej. The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLD. Life 2022; 12(12): 2072 doi: 10.3390/life12122072
|
| 118 |
Shiqin Luo, Yuping Yang, Ting Zhao, Rongping Zhang, Changlong Fang, Yan Li, Zhirong Zhang, Tao Gong. Albumin-Based Silibinin Nanocrystals Targeting Activated Hepatic Stellate Cells for Liver Fibrosis Therapy. ACS Applied Materials & Interfaces 2023; 15(6): 7747 doi: 10.1021/acsami.2c19269
|
| 119 |
Litao Yang, Bo Zhang, Chih-Yuan Ko. Protective Mechanism of Nostoc sphaeroides Kütz. Polysaccharide on Liver Fibrosis by HFD-Induced Liver Fat Synthesis and Oxidative Stress. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/1745244
|
| 120 |
Yi-Jen Liao, Yuan-Hsi Wang, Chao-Lien Liu, Cheng-Chieh Fang, Ming-Hua Hsu, Fat-Moon Suk. 4-Methoxy Sulfonyl Paeonol Inhibits Hepatic Stellate Cell Activation and Liver Fibrosis by Blocking the TGF-β1/Smad, PDGF-BB/MAPK and Akt Signaling Pathways. Applied Sciences 2020; 10(17): 5941 doi: 10.3390/app10175941
|
| 121 |
Rafał Frankowski, Mateusz Kobierecki, Andrzej Wittczak, Monika Różycka-Kosmalska, Tadeusz Pietras, Kasper Sipowicz, Marcin Kosmalski. Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with Inflammation. International Journal of Molecular Sciences 2023; 24(11): 9677 doi: 10.3390/ijms24119677
|
| 122 |
Cai Chen, Xiankui Li, Lei Wang. Thymosinβ4 alleviates cholestatic liver fibrosis in mice through downregulating PDGF/PDGFR and TGFβ/Smad pathways. Digestive and Liver Disease 2020; 52(3): 324 doi: 10.1016/j.dld.2019.08.014
|
| 123 |
Ju-Lu Lu, Chuan-Xin Yu, Li-Jun Song. Programmed cell death in hepatic fibrosis: current and perspectives. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01749-8
|
| 124 |
Sara Della Torre. Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology. Cells 2021; 10(9): 2502 doi: 10.3390/cells10092502
|
| 125 |
Gabriel Costa Monteiro Moreira, Mayara Salvian, Clarissa Boschiero, Aline Silva Mello Cesar, James M. Reecy, Thaís Fernanda Godoy, Mônica Corrêa Ledur, Dorian Garrick, Gerson Barreto Mourão, Luiz L. Coutinho. Genome-wide association scan for QTL and their positional candidate genes associated with internal organ traits in chickens. BMC Genomics 2019; 20(1) doi: 10.1186/s12864-019-6040-3
|
| 126 |
N. Luo, J. Li, Y. Wei, J. Lu, R. Dong. Hepatic Stellate Cell: A Double-Edged Sword in the Liver. Physiological Research 2021; (6): 821 doi: 10.33549/physiolres.934755
|
| 127 |
Kristy Kwan‐Shuen Chan, Kwan‐Yung Au, Wai‐Ching Fung, Cheuk‐Yan Wong, Albert Chi‐Yan Chan, Regina Cheuk‐Lam Lo. Sex‐specific analysis of microRNA profiles in HBV‐associated cirrhosis by small RNA‐sequencing. Hepatology Communications 2022; 6(12): 3473 doi: 10.1002/hep4.2096
|
| 128 |
Hu Li, Pengbo Hu, Yajun Zou, Lijuan Yuan, Yucheng Xu, Xiaohui Zhang, Xiaoyan Luo, Zhiqiang Zhang. Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1071415
|
| 129 |
Rui Li, Zhao Li, Yanru Feng, Hao Yang, Qiuxiao Shi, Ze Tao, Jingqiu Cheng, Xiaofeng Lu. PDGFRβ-targeted TRAIL specifically induces apoptosis of activated hepatic stellate cells and ameliorates liver fibrosis. Apoptosis 2020; 25(1-2): 105 doi: 10.1007/s10495-019-01583-3
|
| 130 |
Yoshinobu Ikeno, Daiya Ohara, Yusuke Takeuchi, Hitomi Watanabe, Gen Kondoh, Kojiro Taura, Shinji Uemoto, Keiji Hirota. Foxp3+ Regulatory T Cells Inhibit CCl4-Induced Liver Inflammation and Fibrosis by Regulating Tissue Cellular Immunity. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.584048
|
| 131 |
Elham Nozari, Ali Moradi, Morteza Samadi. Effect of Atorvastatin, Curcumin, and Quercetin on miR-21 and miR-122 and their correlation with TGFβ1 expression in experimental liver fibrosis. Life Sciences 2020; 259: 118293 doi: 10.1016/j.lfs.2020.118293
|
| 132 |
Thit Mynster Kronborg, Henriette Ytting, Lise Hobolth, Søren Møller, Nina Kimer. Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.718896
|
| 133 |
Verónica Miguel, Santiago Lamas. Oxidative Stress. 2020; : 779 doi: 10.1016/B978-0-12-818606-0.00037-7
|
| 134 |
Xiao-Xue Hou, Yu-Wen Li, Jia-Li Song, Wen Zhang, Rui Liu, Hui Yuan, Tian-Tong Feng, Zheng-Yi Jiang, Wen-Ting Li, Chuan-Long Zhu. Cryptotanshinone induces apoptosis of activated hepatic stellate cells <i>via</i> modulating endoplasmic reticulum stress. World Journal of Gastroenterology 2023; 29(17): 2616-2627 doi: 10.3748/wjg.v29.i17.2616
Abstract(434) |
Core Tip(331) |
Full Article(HTML)(1311)
|
Full Article (PDF)-10240K(96)
|
Full Article (Word)-6027K(24)
|
Audio-698K(0)
|
Peer-Review Report-288K(25)
|
Answering Reviewers-356K(19)
|
Times Cited (0)
|
Total Visits (3757)
|
Open
|
| 135 |
Ho Yin Pekkle Lam, Ting-Ruei Liang, Yi-Chia Lan, Kai-Chih Chang, Po-Ching Cheng, Shih-Yi Peng. Antifibrotic and anthelminthic effect of casticin on Schistosoma mansoni-infected BALB/c mice. Journal of Microbiology, Immunology and Infection 2022; 55(2): 314 doi: 10.1016/j.jmii.2021.03.017
|
| 136 |
Valeria Casotti, Lorenzo D’Antiga. Pediatric Hepatology and Liver Transplantation. 2019; : 21 doi: 10.1007/978-3-319-96400-3_2
|
| 137 |
Michal Safran, Rula Masoud, Maya Sultan, Irena Tachlytski, Chofit Chai Gadot, Ron Pery, Nora Balint-Lahat, Orit Pappo, Nahum Buzaglo, Ziv Ben-Ari. Extracellular Vesicular Transmission of miR-423-5p from HepG2 Cells Inhibits the Differentiation of Hepatic Stellate Cells. Cells 2022; 11(10): 1715 doi: 10.3390/cells11101715
|
| 138 |
Hanzhang Zhu, Yuqiang Shan, Ke Ge, Jun Lu, Wencheng Kong, Changku Jia. Specific Overexpression of Mitofusin-2 in Hepatic Stellate Cells Ameliorates Liver Fibrosis in Mice Model. Human Gene Therapy 2020; 31(1-2): 103 doi: 10.1089/hum.2019.153
|
| 139 |
Johanna Sivunen, Susann Karlberg, Reetta Kivisaari, Jouko Lohi, Niklas Karlberg, Eero Jokinen, Taisto Sarkola, Timo Jahnukainen, Marita Lipsanen‐Nyman, Hannu Jalanko. Liver pathology and biochemistry in patients with mutations in TRIM37 gene (Mulibrey nanism). Liver International 2022; 42(6): 1369 doi: 10.1111/liv.15213
|
| 140 |
S-Q Li, P Wang, D-M Wang, H-J Lu, R-F Li, L-X Duan, S Zhu, S-L Wang, Y-Y Zhang, Y-L Wang. Molecular mechanism for the influence of gender dimorphism on alcoholic liver injury in mice. Human & Experimental Toxicology 2019; 38(1): 65 doi: 10.1177/0960327118777869
|
| 141 |
Yujia Li, Chun Jin, Min Shen, Zhenyi Wang, Shanzhong Tan, Anping Chen, Shijun Wang, Jiangjuan Shao, Feng Zhang, Zili Zhang, Shizhong Zheng. Iron regulatory protein 2 is required for artemether -mediated anti-hepatic fibrosis through ferroptosis pathway. Free Radical Biology and Medicine 2020; 160: 845 doi: 10.1016/j.freeradbiomed.2020.09.008
|
| 142 |
Ya. V. Kiseleva, Yu. O. Zharikov, R. V. Maslennikov, Ch. S. Pavlov, V. N. Nikolenko. Molecular factors associated with regression of liver fibrosis of alcoholic etiology. Terapevticheskii arkhiv 2021; 93(2): 204 doi: 10.26442/00403660.2021.02.200617
|
| 143 |
Lei Xing, Xin Chang, Lijun Shen, Chenglu Zhang, Yatong Fan, Chongsu Cho, Zhiqi Zhang, Hulin Jiang. Progress in drug delivery system for fibrosis therapy. Asian Journal of Pharmaceutical Sciences 2021; 16(1): 47 doi: 10.1016/j.ajps.2020.06.005
|
| 144 |
Sarah B. White, Dilip Rajasekhar Maddirela. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2023; 3: 255 doi: 10.1007/16833_2022_122
|
| 145 |
Taha Aghajanzadeh, Mahmood Talkhabi, Mohammad Reza Zali, Behzad Hatami, Kaveh Baghaei. Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis. Non-coding RNA Research 2023; 8(4): 471 doi: 10.1016/j.ncrna.2023.06.004
|
| 146 |
Munkhzul Ganbold, Yasuhiro Shimamoto, Farhana Ferdousi, Kenichi Tominaga, Hiroko Isoda. Antifibrotic effect of methylated quercetin derivatives on TGFβ-induced hepatic stellate cells. Biochemistry and Biophysics Reports 2019; 20: 100678 doi: 10.1016/j.bbrep.2019.100678
|
| 147 |
Wook Lee, Seung-Jin Kim. Protective effects of isoflavones on alcoholic liver diseases: Computational approaches to investigate the inhibition of ALDH2 with isoflavone analogues. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1147301
|
| 148 |
Sen Yang, Ge Kuang, Rong Jiang, Shengwang Wu, Tao Zeng, Yuanyuan Wang, Fangzhi Xu, Lingyi Xiong, Xia Gong, Jingyuan Wan. Geniposide protected hepatocytes from acetaminophen hepatotoxicity by down-regulating CYP 2E1 expression and inhibiting TLR 4/NF-κB signaling pathway. International Immunopharmacology 2019; 74: 105625 doi: 10.1016/j.intimp.2019.05.010
|
| 149 |
Shanshan Zhu, Tao Wang, Fei Luo, Huawen Li, Qing Jia, Taiping He, Hongfu Wu, Tangbin Zou. Astaxanthin inhibits proliferation and induces apoptosis of LX‑2 cells by regulating the miR‑29b/Bcl‑2 pathway. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10025
|
| 150 |
Ming Li, Zhifeng Yang, Zhaoyuan Song, Cunxiang Bo, Shuo Wang, Qiang Jia. ATM deficiency aggravates the progression of liver fibrosis induced by carbon tetrachloride in mice. Toxicology 2023; 484: 153397 doi: 10.1016/j.tox.2022.153397
|
| 151 |
Joseph George. Determination of selenium during pathogenesis of hepatic fibrosis employing hydride generation and inductively coupled plasma mass spectrometry. Biological Chemistry 2018; 399(5): 499 doi: 10.1515/hsz-2017-0260
|
| 152 |
Gabriel Barros Rodrigues, Elquio Eleamen Oliveira, Francisco Jaime Bezerra Mendonça Junior, Laise Aline Martins dos Santos, Wilma Helena de Oliveira, Maria Eduarda Rocha de França, Deniele Bezerra Lós, Brennda Martins Gabínio, Christina Alves Peixoto. A new diethylcarbamazine formulation (NANO-DEC) as a therapeutic tool for hepatic fibrosis. International Immunopharmacology 2018; 64: 280 doi: 10.1016/j.intimp.2018.09.010
|
| 153 |
Mohamed Salama, Manal Nomir, Maryan Fahmi, Amal El-Gayar, Mamdouh El-Shishtawy. Potential Role of Microfibrillar-Associated Protein 4, Fibrotic Indices and Oxidative Stress in Hepatocellular Carcinoma. Scientia Pharmaceutica 2018; 86(4): 44 doi: 10.3390/scipharm86040044
|
| 154 |
Xiao-rong Pan, Ying-ying Jing, Wen-ting Liu, Zhi-peng Han, Rong Li, Yang Yang, Jing-ni Zhu, Xiao-yong Li, Pei-pei Li, Li-xin Wei. Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts via activation of the Hedgehog signaling pathway. Cell Cycle 2017; 16(14): 1357 doi: 10.1080/15384101.2017.1325976
|
| 155 |
Erjin Wang, Xingxuan He, Ming Zeng. The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis. Frontiers in Pharmacology 2019; 9 doi: 10.3389/fphar.2018.01504
|
| 156 |
Sander van Riet, Anais Julien, Andrea Atanasov, Åsa Nordling, Magnus Ingelman-Sundberg. The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model. Hepatology Communications 2024; 8(3) doi: 10.1097/HC9.0000000000000374
|
| 157 |
Wei Huang, Feizhou Huang, Rui Zhang, Hongwu Luo. LncRNA Neat1 expedites the progression of liver fibrosis in mice through targeting miR-148a-3p and miR-22-3p to upregulate Cyth3. Cell Cycle 2021; 20(5-6): 490 doi: 10.1080/15384101.2021.1875665
|
| 158 |
Shuang Ren, Jiamei Chen, Qinglan Wang, Xuewei Li, Ying Xu, Xiao Zhang, Yongping Mu, Hua Zhang, Shuang Huang, Ping Liu. MicroRNA-744/transforming growth factor β1 relationship regulates liver cirrhosis. Hepatology International 2019; 13(6): 814 doi: 10.1007/s12072-019-09993-w
|
| 159 |
Eline Geervliet, Silvia Moreno, Luca Baiamonte, Richell Booijink, Susanne Boye, Peng Wang, Brigitte Voit, Albena Lederer, Dietmar Appelhans, Ruchi Bansal. Matrix metalloproteinase-1 decorated polymersomes, a surface-active extracellular matrix therapeutic, potentiates collagen degradation and attenuates early liver fibrosis. Journal of Controlled Release 2021; 332: 594 doi: 10.1016/j.jconrel.2021.03.016
|
| 160 |
Rimpy Diwan, Samantha Lynn Gaytan, Himanshu Narendrakumar Bhatt, Jacqueline Pena-Zacarias, Md Nurunnabi. Liver fibrosis pathologies and potentials of RNA based therapeutics modalities. Drug Delivery and Translational Research 2024; doi: 10.1007/s13346-024-01551-8
|
| 161 |
Sandra Calixto-Tlacomulco, Ismael Luna-Reyes, Blanca Delgado-Coello, Roxana Gutiérrez-Vidal, Juan Pablo Reyes-Grajeda, Jaime Mas-Oliva. CETP-derived Peptide Seq-1, the Key Component of HB-ATV-8 Vaccine Prevents Stress Responses, and Promotes Downregulation of Pro-Fibrotic Genes in Hepatocytes and Stellate Cells. Archives of Medical Research 2024; 55(2): 102937 doi: 10.1016/j.arcmed.2023.102937
|
| 162 |
Man Li, Fu-Sheng He, Long-Shan Ji, Ya-Ting Gao, Xin Zhang, Zhuo Yu, Miao Fang, Jie Wu, Yue-Qiu Gao. Synthesis and biological evaluation of fluorinated 3,4-dihydroquinolin-2(1H)-ones and 2-oxindoles for anti-hepatic fibrosis. RSC Advances 2021; 11(11): 5923 doi: 10.1039/D0RA09430G
|
| 163 |
Wei Liang, Xianing Huang, Jingjing Shi. Macrophages Serve as Bidirectional Regulators and Potential Therapeutic Targets for Liver Fibrosis. Cell Biochemistry and Biophysics 2023; 81(4): 659 doi: 10.1007/s12013-023-01173-w
|
| 164 |
Sara Della Torre. Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.572490
|
| 165 |
Hui Yang, Juan Wang, Zhen‐Guo Liu. Multi‐faceted role of pyroptosis mediated by inflammasome in liver fibrosis. Journal of Cellular and Molecular Medicine 2022; 26(10): 2757 doi: 10.1111/jcmm.17277
|
| 166 |
Yufeng Sun, Lili He, Peiran Guo, Fenghua Li, Bo Wang, Yifan Zhang, Kai An, Ming Peng. F-box and WD repeat domain containing 7 inhibits the activation of hepatic stellate cells by degrading delta-like ligand 1 to block Notch signaling pathway. Open Medicine 2023; 18(1) doi: 10.1515/med-2023-0634
|
| 167 |
Matheus Scherer Bastos, Rafaela Mallmann Saalfeld, Bruna Pasqualotto Costa, Krist Helen Antunes, Denizar Melo, Márcio Vinicius Fagundes Donadio, Eliane Romanato Santarém, Jarbas Rodrigues de Oliveira. Coumaric acid from M. polymorphum extracts reverses the activated state of hepatic stellate cells (GRX) and inhibits their proliferation by decreasing the p53/p21 pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 2023; 396(5): 925 doi: 10.1007/s00210-022-02361-w
|
| 168 |
Veruska Cintia Alexandrino de Souza, Danielle Maria Nascimento Moura, Maria Carolina Accioly Brelaz de Castro, Patrícia Torres Bozza, Ligia de Almeida Paiva, Camila Juliet Barbosa Fernandes, Renata Lins Carneiro Leão, Jéssica Paula Lucena, Roni Evencio de Araujo, Alex José de Melo Silva, Regina Celia Bressan Queiroz Figueiredo, Sheilla Andrade de Oliveira. Adoptive Transfer of Bone Marrow-Derived Monocytes Ameliorates Schistosoma mansoni -Induced Liver Fibrosis in Mice. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-42703-y
|
| 169 |
Aparna Ann Mathew, Rajitha Panonnummal. ‘Magnesium’-the master cation-as a drug—possibilities and evidences. BioMetals 2021; 34(5): 955 doi: 10.1007/s10534-021-00328-7
|
| 170 |
Lianjie Xu, Yurong Zhang, Nengbo Ji, Yan Du, Tao Jia, Shanshan Wei, Wei Wang, Shan Zhang, Wenhui Chen. Tanshinone IIA regulates the TGF‑β1/Smad signaling pathway to ameliorate non‑alcoholic steatohepatitis‑related fibrosis. Experimental and Therapeutic Medicine 2022; 24(1) doi: 10.3892/etm.2022.11413
|
| 171 |
Hsiao-Hsuan Wang, Jian-Hao Huang, Min-Hao Sue, Wei-Chih Ho, Yu-Hsiang Hsu, Kung-Chao Chang, Ming-Shi Chang. Interleukin-24 protects against liver injury in mouse models. EBioMedicine 2021; 64: 103213 doi: 10.1016/j.ebiom.2021.103213
|
| 172 |
Ao Wang, Fang-tian Bu, Juan-juan Li, Ya-fei Zhang, Peng-cheng Jia, Hong-mei You, Sha Wu, Yuan-yuan Wu, Sai Zhu, Cheng Huang, Jun Li. MicroRNA-195-3p promotes hepatic stellate cell activation and liver fibrosis by suppressing PTEN expression. Toxicology Letters 2022; 355: 88 doi: 10.1016/j.toxlet.2021.11.014
|
| 173 |
Li Ma, Junping Liu, Erhui Xiao, Huibin Ning, Kuan Li, Jia Shang, Yi Kang. MiR-15b and miR-16 suppress TGF-β1-induced proliferation and fibrogenesis by regulating LOXL1 in hepatic stellate cells. Life Sciences 2021; 270: 119144 doi: 10.1016/j.lfs.2021.119144
|
| 174 |
Jiulong Li, Chunying Chen, Tian Xia. Understanding Nanomaterial–Liver Interactions to Facilitate the Development of Safer Nanoapplications. Advanced Materials 2022; 34(11) doi: 10.1002/adma.202106456
|
| 175 |
Zhaoguo Liu, Song Zhou, Ya Zhang, Ming Zhao. Rat bone marrow mesenchymal stem cells (BMSCs) inhibit liver fibrosis by activating GSK3β and inhibiting the Wnt3a/β-catenin pathway. Infectious Agents and Cancer 2022; 17(1) doi: 10.1186/s13027-022-00432-4
|
| 176 |
Gabriela Yuri, Sofía Sanhueza, Adrián Paredes, Glauco Morales, Mariana Cifuentes, Paulina Ormazabal. Deleterious liver-adipose crosstalk in obesity: Hydroethanolic extract of Lampaya medicinalis Phil. (Verbenaceae) counteracts fatty acid-induced fibrotic marker expression in human hepatocytes. Molecular and Cellular Endocrinology 2023; 564: 111882 doi: 10.1016/j.mce.2023.111882
|
| 177 |
Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Cells 2019; 8(10): 1259 doi: 10.3390/cells8101259
|
| 178 |
Einat Rauchbach, Haim Zeigerman, Diana Abu-Halaka, Oren Tirosh. Cholesterol Induces Oxidative Stress, Mitochondrial Damage and Death in Hepatic Stellate Cells to Mitigate Liver Fibrosis in Mice Model of NASH. Antioxidants 2022; 11(3): 536 doi: 10.3390/antiox11030536
|
| 179 |
Yan Lv, Nishant Patel, Hai-Jun Zhang. The progress of non-alcoholic fatty liver disease as the risk of liver metastasis in colorectal cancer. Expert Review of Gastroenterology & Hepatology 2019; 13(12): 1169 doi: 10.1080/17474124.2019.1697231
|
| 180 |
Eun-Ho Lee, Jae-Ho Lee, Do-Young Kim, Young-Seung Lee, Yunju Jo, Tam Dao, Kyung Eun Kim, Dae-Kyu Song, Ji Hae Seo, Young-Kyo Seo, Je Kyung Seong, Changjong Moon, Eugene Han, Mi Kyung Kim, Seungwan Ryu, Minsang Shin, Gu Seob Roh, Hye Ra Jung, Timothy F. Osborne, Dongryeol Ryu, Tae-Il Jeon, Seung-Soon Im. Loss of SREBP-1c ameliorates iron-induced liver fibrosis by decreasing lipocalin-2. Experimental & Molecular Medicine 2024; doi: 10.1038/s12276-024-01213-2
|
| 181 |
Shobhit Verma, Sharmeen Ishteyaque, Kaveri R. Washimkar, Smriti Verma, Madhav Nilakanth Mugale. Mitochondrial-mediated nuclear remodeling and macrophage polarizations: A key switch from liver fibrosis to HCC progression. Experimental Cell Research 2024; 434(1): 113878 doi: 10.1016/j.yexcr.2023.113878
|
| 182 |
Rui Feng, Weixing Du, Ping Lui, Jun Zhang, Yanqing Liu. CAPN2 acts as an indicator of hepatitis B virus to induce hepatic fibrosis. Journal of Cellular Biochemistry 2020; 121(3): 2428 doi: 10.1002/jcb.29465
|
| 183 |
Yong Joo Park, Mi Seon Jeon, Seulah Lee, Jung Kyu Kim, Tae Su Jang, Kyu Hyuck Chung, Ki Hyun Kim. Anti-fibrotic effects of brevilin A in hepatic fibrosis via inhibiting the STAT3 signaling pathway. Bioorganic & Medicinal Chemistry Letters 2021; 41: 127989 doi: 10.1016/j.bmcl.2021.127989
|
| 184 |
Yong Joo Park, Hyoung-Tae An, Jong-Sung Park, Ogyi Park, Alexander J. Duh, Kwangmeyung Kim, Kyu Hyuck Chung, Kang Choon Lee, Yumin Oh, Seulki Lee. Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-71688-2
|
| 185 |
Qi Cheng, Chen Li, Cheng-fang Yang, Yu-juan Zhong, Dan Wu, Lin Shi, Li Chen, Yong-wen Li, Li Li. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways. Chemico-Biological Interactions 2019; 299: 131 doi: 10.1016/j.cbi.2018.12.006
|
| 186 |
Xu-Huang Fu, Cheng-Zhen Chen, Ying Wang, Yan-Xia Peng, Wen-Hua Wang, Bao Yuan, Yan Gao, Hao Jiang, Jia-Bao Zhang. COL1A1 affects apoptosis by regulating oxidative stress and autophagy in bovine cumulus cells. Theriogenology 2019; 139: 81 doi: 10.1016/j.theriogenology.2019.07.024
|
| 187 |
Jennifer C. Ku, Jacob Raiten, Yong Li. Understanding fibrosis: Mechanisms, clinical implications, current therapies, and prospects for future interventions. Biomedical Engineering Advances 2024; 7: 100118 doi: 10.1016/j.bea.2024.100118
|
| 188 |
Zhengrong Xu, Tao Li, Man Li, Lei Yang, Rudan Xiao, Li Liu, Xin Chi, Dianwu Liu. eRF3b-37 inhibits the TGF-β1-induced activation of hepatic stellate cells by regulating cell proliferation, G0/G1 arrest, apoptosis and migration. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3900
|
| 189 |
Yun Wang, Dongliang Yan. Plantamajoside exerts antifibrosis effects in the liver by inhibiting hepatic stellate cell activation. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7843
|
| 190 |
Ayman M. Mahmoud, Walaa G. Hozayen, Iman H. Hasan, Eman Shaban, May Bin-Jumah. Umbelliferone Ameliorates CCl4-Induced Liver Fibrosis in Rats by Upregulating PPARγ and Attenuating Oxidative Stress, Inflammation, and TGF-β1/Smad3 Signaling. Inflammation 2019; 42(3): 1103 doi: 10.1007/s10753-019-00973-8
|
| 191 |
Menna Azzam, Sara El Safy, Sarah A. Abdelgelil, Ralf Weiskirchen, Anastasia Asimakopoulou, Federica de Lorenzi, Twan Lammers, Samar Mansour, Salma Tammam. Targeting Activated Hepatic Stellate Cells Using Collagen-Binding Chitosan Nanoparticles for siRNA Delivery to Fibrotic Livers. Pharmaceutics 2020; 12(6): 590 doi: 10.3390/pharmaceutics12060590
|
| 192 |
Masayoshi Takeuchi, Akiko Sakasai-Sakai, Takanobu Takata, Jun-ichi Takino, Yoshiki Koriyama, Chigusa Kikuchi, Ayako Furukawa, Kentaro Nagamine, Takamitsu Hori, Tamihide Matsunaga. Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage. Biomolecules 2021; 11(3): 387 doi: 10.3390/biom11030387
|
| 193 |
Ju Zhou, Qing Lan, Wu Li, Lin Yang, Jing You, Yan‐Mei Zhang, Wei Ni. Tripartite motif protein 52 (TRIM52) promoted fibrosis in LX‐2 cells through PPM1A‐mediated Smad2/3 pathway. Cell Biology International 2020; 44(1): 108 doi: 10.1002/cbin.11206
|
| 194 |
Yi Ding, Qiulin Luo, Hanyun Que, Nan Wang, Puyang Gong, Jian Gu. Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Agent for the Treatment of Liver Diseases. International Journal of Molecular Sciences 2022; 23(18): 10972 doi: 10.3390/ijms231810972
|
| 195 |
Wenyi Wang, Yu Zhang, Yue Jiang, Yujie Wang, Junfeng Zhu, Chunli Wang, Xianghui Han, Jianyi Wang. Exploration of potential mechanism of Rougan formula against hepatic fibrosis by network analysis and experimental assessment. Journal of Ethnopharmacology 2023; 304: 115960 doi: 10.1016/j.jep.2022.115960
|
| 196 |
Konstantinos Kounakis, Manos Chaniotakis, Maria Markaki, Nektarios Tavernarakis. Emerging Roles of Lipophagy in Health and Disease. Frontiers in Cell and Developmental Biology 2019; 7 doi: 10.3389/fcell.2019.00185
|
| 197 |
Fengming Xu, Hans-Michael Tautenhahn, Olaf Dirsch, Uta Dahmen, Miguel Sánchez Álvarez. Modulation of Autophagy: A Novel “Rejuvenation” Strategy for the Aging Liver. Oxidative Medicine and Cellular Longevity 2021; 2021: 1 doi: 10.1155/2021/6611126
|
| 198 |
Naga Chalasani, Raj Vuppalanchi, Craig Lammert, Samer Gawrieh, Jerome V. Braun, Jiali Zhuang, Arkaitz Ibarra, David A. Ross, Michael Nerenberg, Stephen R. Quake, John J. Sninsky, Shusuke Toden. Circulating cell-free messenger RNA secretome characterization of primary sclerosing cholangitis. Hepatology Communications 2023; 7(6) doi: 10.1097/HC9.0000000000000140
|
| 199 |
A.A. Elhenawy, M.S. Elmehankar, N. Nabih, M.A. Elzoheiry, H. Hany, R. El-Gamal, W.A. Aboukamar. Biochanin A in murine Schistosoma mansoni infection: effects on inflammation, oxidative stress and fibrosis. Journal of Helminthology 2023; 97 doi: 10.1017/S0022149X22000839
|
| 200 |
Fat-Moon Suk, Fang-Yu Hsu, Yi-Chieh Lee, Tzu-Lang Chen, Wan-Chun Chiu, Yi-Jen Liao. Dietary oxidized frying oil activates hepatic stellate cells and accelerates the severity of carbon tetrachloride- and thioacetamide-induced liver fibrosis in mice. The Journal of Nutritional Biochemistry 2023; 115: 109267 doi: 10.1016/j.jnutbio.2023.109267
|
| 201 |
Sean A. Dilliard, Daniel J. Siegwart. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nature Reviews Materials 2023; 8(4): 282 doi: 10.1038/s41578-022-00529-7
|
| 202 |
Haena Choi, Daehyun Oh, Hyeon-Ji Kim, Melody Chambugong, Mi-hyun Kim, Mi-Ock Lee, Hyeung-geun Park. An RORα agonist, ODH-08, inhibits fibrogenic activation of hepatic stellate cells via suppression of SMAD3. Life Sciences 2024; 340: 122443 doi: 10.1016/j.lfs.2024.122443
|
| 203 |
Natural Sulfur-Containing Compounds: An Alternative Therapeutic Strategy against Liver Fibrosis. Cells 2019; 8(11): 1356 doi: 10.3390/cells8111356
|
| 204 |
Wen-Ling Mou, Shi-Ru Chen, Zhen-Ting Wu, Li-Hua Hu, Ji-Ye Zhang, Hong-Jie Chang, Hang Zhou, Ying Liu. LPS-TLR4/MD-2–TNF-α signaling mediates alcohol-induced liver fibrosis in rats. Journal of Toxicologic Pathology 2022; 35(2): 193 doi: 10.1293/tox.2021-0018
|
| 205 |
Mahmoud A. Younis, Yusuke Sato, Yaser H.A. Elewa, Hideyoshi Harashima. Reprogramming activated hepatic stellate cells by siRNA-loaded nanocarriers reverses liver fibrosis in mice. Journal of Controlled Release 2023; 361: 592 doi: 10.1016/j.jconrel.2023.08.021
|
| 206 |
Xin Wang, Hui Liu, Yuqi Wang, Peng Wang, Yunyun Yi, Yingying Lin, Xin Li. Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway. Journal of Gastroenterology and Hepatology 2024; doi: 10.1111/jgh.16538
|
| 207 |
Shuoxi Xu, Yonger Chen, Jindian Miao, Yuhua Li, Jiaying Liu, Jing zhang, Jian Liang, Shuxian Chen, Shaozhen Hou. Esculin inhibits hepatic stellate cell activation and CCl4-induced liver fibrosis by activating the Nrf2/GPX4 signaling pathway. Phytomedicine 2024; 128: 155465 doi: 10.1016/j.phymed.2024.155465
|
| 208 |
Mrigendra Bir Karmacharya, Binika Hada, So Ra Park, Kil Hwan Kim, Byung Hyune Choi, Wenyu Lin. Granulocyte-macrophage colony-stimulating factor (GM-CSF) shows therapeutic effect on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. PLOS ONE 2022; 17(9): e0274126 doi: 10.1371/journal.pone.0274126
|
| 209 |
Fengming Tian, Yumei Liu, Jian Gao, Ning Yang, Xiaoqian Shang, Jie Lv, Derong Ba, Xuan Zhou, Chuntao Zhang, Xiumin Ma. Study on the association between TGF‑β1 and liver fibrosis in patients with hepatic cystic echinococcosis. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.8355
|
| 210 |
Xudong Song, Jiayi Shi, Jieting Liu, Yong Liu, Yang Yu, Yufei Qiu, Zhiqin Cao, Yu Pan, Xiaohuan Yuan, Yanhui Chu, Dan Wu. Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-β/Smad pathway. Molecular Medicine 2022; 28(1) doi: 10.1186/s10020-022-00508-2
|
| 211 |
Rong Qin, Weikang Huang, Yun Huang, Zhibo Zhang, Yu Su, Sijin Chen, Hui Wang. lncRNA MEG3 modulates hepatic stellate cell activation by sponging miR‑145 to regulate PPARγ. Molecular Medicine Reports 2021; 25(1) doi: 10.3892/mmr.2021.12519
|
| 212 |
Yan-Ming Bai, Shuang Liang, Bo Zhou. Revealing immune infiltrate characteristics and potential immune-related genes in hepatic fibrosis: based on bioinformatics, transcriptomics and q-PCR experiments. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1133543
|
| 213 |
Yukimasa Makita, Shumpei Murata, Yoshiki Katou, Kuniko Kikuchi, Hiroshi Uejima, Mika Teratani, Yasutaka Hoashi, Eriya Kenjo, Satoru Matsumoto, Masahiro Nogami, Kentaro Otake, Yuji Kawamata. Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2017; 493(1): 800 doi: 10.1016/j.bbrc.2017.08.088
|
| 214 |
Jinhui Du, Likun Liu, Haiqing Fan, Yue Yu, Yilin Luo, Fang Gu, Hui Yu, Xin Liao. Anthocyanins improve liver fibrosis in mice by regulating the autophagic flux level of hepatic stellate cells by mmu_circ_0000623. Food Science & Nutrition 2023; 11(6): 3002 doi: 10.1002/fsn3.3281
|
| 215 |
Tanmoy Banerjee, Arnab Sarkar, Sk Zeeshan Ali, Rudranil Bhowmik, Sanmoy Karmakar, Amit Kumar Halder, Nilanjan Ghosh. Bioprotective Role of Phytocompounds Against the Pathogenesis of Non-alcoholic Fatty Liver Disease to Non-alcoholic Steatohepatitis: Unravelling Underlying Molecular Mechanisms. Planta Medica 2024; doi: 10.1055/a-2277-4805
|
| 216 |
Yang Zheng, Jiaru Wang, Tiejian Zhao, Lei Wang, Jiahui Wang. Modulation of the VEGF/AKT/eNOS signaling pathway to regulate liver angiogenesis to explore the anti-hepatic fibrosis mechanism of curcumol. Journal of Ethnopharmacology 2021; 280: 114480 doi: 10.1016/j.jep.2021.114480
|
| 217 |
Azam Moslehi, Tahereh Komeili-Movahed. The Effects of Rosmarinic Acid on the Liver Fibrosis Induced by Non-alcoholic Steatohepatitis in Male Mice. Qom Univ Med Sci J 2021; 15(1): 2 doi: 10.52547/qums.15.1.2
|
| 218 |
Na Fu, Dongdong Li, Wencong Li, Wen Zhao, Siyu Zhang, Lingdi Liu, Suxian Zhao, Jinghua Du, Lingbo Kong, Rongqi Wang, Yuguo Zhang, Yuemin Nan. Glutamate-Cysteine Ligase Catalytic Subunit Attenuated Hepatitis C Virus-Related Liver Fibrosis and Suppressed Endoplasmic Reticulum Stress. Frontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.00199
|
| 219 |
Carlos Sanz-García, Anabel Fernández-Iglesias, Jordi Gracia-Sancho, Luis Alfonso Arráez-Aybar, Yulia A. Nevzorova, Francisco Javier Cubero. The Space of Disse: The Liver Hub in Health and Disease. Livers 2021; 1(1): 3 doi: 10.3390/livers1010002
|
| 220 |
Raquel Fernández-Ginés, José Antonio Encinar, Maribel Escoll, Daniel Carnicero-Senabre, José Jiménez-Villegas, Ángel J. García-Yagüe, Águeda González-Rodríguez, Irma Garcia-Martinez, A.M. Valverde, Ana I. Rojo, Antonio Cuadrado. Specific targeting of the NRF2/β-TrCP axis promotes beneficial effects in NASH. Redox Biology 2024; 69: 103027 doi: 10.1016/j.redox.2024.103027
|
| 221 |
Kaj E.C. Blokland, Simon D. Pouwels, Michael Schuliga, Darryl A. Knight, Janette K. Burgess. Regulation of cellular senescence by extracellular matrix during chronic fibrotic diseases. Clinical Science 2020; 134(20): 2681 doi: 10.1042/CS20190893
|
| 222 |
Guo Zhou, Jiaxin Bei, Tianyang Li, Kangshun Zhu, Zhengkun Tu. TLR3 Mediates Senescence and Immunosurveillance of Hepatic Stellate Cells. Hepatitis Monthly 2021; 21(6) doi: 10.5812/hepatmon.114381
|
| 223 |
Kyohei Takano, Marisa Kaneda, Yayoi Aoki, Nina Fujita, Shigeki Chiba, Seiwa Michihara, Li-Kun Han, Ryuji Takahashi. The protective effects of Ninjin’yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse. Journal of Natural Medicines 2024; doi: 10.1007/s11418-024-01786-2
|
| 224 |
Gao-Liang Zou, Shi Zuo, Shuang Lu, Rui-Han Hu, Yin-Ying Lu, Jing Yang, Kai-Sheng Deng, Ye-Ting Wu, Mao Mu, Juan-Juan Zhu, Jing-Zhang Zeng, Bao-Fang Zhang, Xian Wu, Xue-Ke Zhao, Hai-Yang Li. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis <i>via</i> regulation of TGF-β/Smad signaling pathway. World Journal of Gastroenterology 2019; 25(30): 4222-4234 doi: 10.3748/wjg.v25.i30.4222
|
| 225 |
Xiaoqiang Qi, Ming Yang, Joseph Stenberg, Rahul Dey, Leslie Fogwe, Muhammad Shawkat Alam, Eric T Kimchi, Kevin F Staveley-O'Carroll, Guangfu Li. Gut microbiota mediated molecular events and therapy in liver diseases. World Journal of Gastroenterology 2020; 26(48): 7603-7618 doi: 10.3748/wjg.v26.i48.7603
|
| 226 |
Hyuk Cheol Kwon, Hyejin Sohn, Do Hyun Kim, Dong Min Shin, Chang Hee Jeong, You Hyun Chang, Jong Hyeok Yune, Yea Ji Kim, Dong-Wook Kim, Sang Ho Kim, Sung Gu Han. In Vitro and In Vivo Study on the Toxic Effects of Propiconazole Fungicide in the Pathogenesis of Liver Fibrosis. Journal of Agricultural and Food Chemistry 2021; 69(26): 7399 doi: 10.1021/acs.jafc.1c01086
|
| 227 |
Chien-Hao Huang, Victor Chien-Chia Wu, Chun-Li Wang, Chia-Ling Wu, Yu-Tung Huang, Shang-Hung Chang. Silymarin Synergizes with Antiviral Therapy in Hepatitis B Virus-Related Liver Cirrhosis: A Propensity Score Matching Multi-Institutional Study. International Journal of Molecular Sciences 2024; 25(6): 3088 doi: 10.3390/ijms25063088
|
| 228 |
Qiuju Li, Han Kang, Rongguo Zhang, Qiyong Guo. Non-invasive precise staging of liver fibrosis using deep residual network model based on plain CT images. International Journal of Computer Assisted Radiology and Surgery 2022; 17(4): 627 doi: 10.1007/s11548-022-02573-8
|
| 229 |
Gaiping Wang, Jiahui Tong, Yingle Li, Xianglei Qiu, Anqi Chen, Cuifang Chang, Guoying Yu. Overview of CircRNAs Roles and Mechanisms in Liver Fibrosis. Biomolecules 2023; 13(6): 940 doi: 10.3390/biom13060940
|
| 230 |
Richa Thakur, Anshuk Sharma, Madhu C. Lingaraju, Jubeda Begum, Dhirendra Kumar, Karikalan Mathesh, Pawan Kumar, Thakur Uttam Singh, Dinesh Kumar. Ameliorative effect of ursolic acid on renal fibrosis in adenine-induced chronic kidney disease in rats. Biomedicine & Pharmacotherapy 2018; 101: 972 doi: 10.1016/j.biopha.2018.02.143
|
| 231 |
Jeffrey Barr Warner, Steven Corrigan Guenthner, Josiah Everett Hardesty, Craig James McClain, Dennis Ray Warner, Irina Andreyevna Kirpich. Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease. World Journal of Gastroenterology 2022; 28(36): 5280-5299 doi: 10.3748/wjg.v28.i36.5280
|
| 232 |
Zhun Xiao, Qiang Ji, Ya-dong Fu, Si-qi Gao, Yong-hong Hu, Wei Liu, Gao-feng Chen, Yong-ping Mu, Jia-mei Chen, Ping Liu. Amygdalin Ameliorates Liver Fibrosis through Inhibiting Activation of TGF-β/Smad Signaling. Chinese Journal of Integrative Medicine 2023; 29(4): 316 doi: 10.1007/s11655-021-3304-y
|
| 233 |
Honglin Jiang, Ning Xu, Wei Zhang, Hongjian Wei, Yue Chen, Qingwu Jiang, Yibiao Zhou. Do gut microbiome‐targeted therapies improve liver function in cirrhotic patients? A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2023; 38(11): 1900 doi: 10.1111/jgh.16329
|
| 234 |
Po-Jen Chen, Liang-Mou Kuo, Yi-Hsiu Wu, Yu-Chia Chang, Kuei-Hung Lai, Tsong-Long Hwang. BAY 41-2272 Attenuates CTGF Expression via sGC/cGMP-Independent Pathway in TGFβ1-Activated Hepatic Stellate Cells. Biomedicines 2020; 8(9): 330 doi: 10.3390/biomedicines8090330
|
| 235 |
Jiunn-Sheng Wu, Valeria Chiu, Chou-Chin Lan, Ming-Chieh Wang, I.-Shiang Tzeng, Chan-Yen Kuo, Po-Chun Hsieh. Chrysophanol Prevents Lipopolysaccharide-Induced Hepatic Stellate Cell Activation by Upregulating Apoptosis, Oxidative Stress, and the Unfolded Protein Response. Evidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/8426051
|
| 236 |
Kuo Du, Seh Hoon Oh, Rajesh K. Dutta, Tianai Sun, Wen‐Hsuan Yang, Jen‐Tsan Chi, Anna Mae Diehl. Inhibiting xCT/SLC7A11 induces ferroptosis of myofibroblastic hepatic stellate cells but exacerbates chronic liver injury. Liver International 2021; 41(9): 2214 doi: 10.1111/liv.14945
|
| 237 |
Bayan Y. Ghanim, Nidal A. Qinna. Nrf2/ARE axis signalling in hepatocyte cellular death. Molecular Biology Reports 2022; 49(5): 4039 doi: 10.1007/s11033-022-07125-6
|
| 238 |
Shahrbanoo Keshavarz Azizi Raftar, Sara Abdollahiyan, Masoumeh Azimirad, Abbas Yadegar, Farzam Vaziri, Arfa Moshiri, Seyed Davar Siadat, Mohammad Reza Zali. The Anti-fibrotic Effects of Heat-Killed Akkermansia muciniphila MucT on Liver Fibrosis Markers and Activation of Hepatic Stellate Cells. Probiotics and Antimicrobial Proteins 2021; 13(3): 776 doi: 10.1007/s12602-020-09733-9
|
| 239 |
Fabio Sabbadini, Monica Bertolini, Serena De Matteis, Domenico Mangiameli, Serena Contarelli, Silvia Pietrobono, Davide Melisi. The Multifaceted Role of TGF-β in Gastrointestinal Tumors. Cancers 2021; 13(16): 3960 doi: 10.3390/cancers13163960
|
| 240 |
Merve Özel, Mevlut Baskol, Hilal Akalın, Gulden Baskol. Suberoylanilide Hydroxamic Acid (SAHA) Reduces Fibrosis Markers and Deactivates Human Stellate Cells via the Epithelial–Mesenchymal Transition (EMT). Cell Biochemistry and Biophysics 2021; 79(2): 349 doi: 10.1007/s12013-021-00974-1
|
| 241 |
Mahesh Devarasetty, Steven D. Forsythe, Ethan Shelkey, Shay Soker. In Vitro Modeling of the Tumor Microenvironment in Tumor Organoids. Tissue Engineering and Regenerative Medicine 2020; 17(6): 759 doi: 10.1007/s13770-020-00258-4
|
| 242 |
Mei-Lin Peng, Li-Jie Zhang, Yan Luo, Shi-Ying Xu, Xing-Mei Long, Jun-Li Ao, Shang-Gao Liao, Qin-Feng Zhu, Xun He, Guo-Bo Xu. Phomopsterone B Alleviates Liver Fibrosis through mTOR-Mediated Autophagy and Apoptosis Pathway. Molecules 2024; 29(2): 417 doi: 10.3390/molecules29020417
|
| 243 |
Ji Hye Jun, Soo Young Park, Sohae Park, Hee Jung Park, Jae Yeon Kim, Gyu Tae Park, Si Hyun Bae, Jae Ho Kim, Gi Jin Kim. Formyl Peptide Receptor 2 Alleviates Hepatic Fibrosis in Liver Cirrhosis by Vascular Remodeling. International Journal of Molecular Sciences 2021; 22(4): 2107 doi: 10.3390/ijms22042107
|
| 244 |
Cristina Stasi, Stefano Milani, Andrea Galli. The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes. 2021; : 129 doi: 10.1016/B978-0-12-821927-0.00005-X
|
| 245 |
Shahla Asadizadeh, Mahdi Hatami, Samaneh Salehipour Bavarsad, Benyamin Kabizade, Elham Shakerian, Mojtaba Rashidi. Curcumin Modulates NOX Gene Expression and ROS Production via P-Smad3C in TGF-β-Activated Hepatic Stellate Cells. Iranian Biomedical Journal 2024; 28(1): 31 doi: 10.61186/ibj.4005
|
| 246 |
|
| 247 |
Yang Zheng, Tiejian Zhao, Jiaru Wang, Ruizhu Jiang, Jinbiao Huang, Weimin Li, Jiahui Wang. Curcumol alleviates liver fibrosis through inducing autophagy and ferroptosis in hepatic stellate cells. The FASEB Journal 2022; 36(12) doi: 10.1096/fj.202200933RR
|
| 248 |
Panuwat Trairatphisan, Terezinha Maria de Souza, Jos Kleinjans, Danyel Jennen, Julio Saez-Rodriguez. Contextualization of causal regulatory networks from toxicogenomics data applied to drug-induced liver injury. Toxicology Letters 2021; 350: 40 doi: 10.1016/j.toxlet.2021.06.020
|
| 249 |
Peilin Li, Daisuke Miyamoto, Yu Huang, Tomohiko Adachi, Masaaki Hidaka, Takanobu Hara, Akihiko Soyama, Hajime Matsushima, Hajime Imamura, Kengo Kanetaka, Weili Gu, Susumu Eguchi. Three-dimensional human bile duct formation from chemically induced human liver progenitor cells. Frontiers in Bioengineering and Biotechnology 2023; 11 doi: 10.3389/fbioe.2023.1249769
|
| 250 |
Weiwei Liu, Tao Hou, Xing Zhang, Hui He. TGF-β1/Smad7 signaling pathway and cell apoptosis: Two key aspects of Selenium-biofortified soybean peptide attenuating liver fibrosis. Journal of Functional Foods 2019; 63: 103583 doi: 10.1016/j.jff.2019.103583
|
| 251 |
Olga Pivovarova-Ramich, Jennifer Loske, Silke Hornemann, Mariya Markova, Nicole Seebeck, Anke Rosenthal, Frederick Klauschen, José Castro, René Buschow, Tilman Grune, Volker Lange, Natalia Rudovich, D. Ouwens. Hepatic Wnt1 Inducible Signaling Pathway Protein 1 (WISP-1/CCN4) Associates with Markers of Liver Fibrosis in Severe Obesity. Cells 2021; 10(5): 1048 doi: 10.3390/cells10051048
|
| 252 |
Fangbin Liu, Shengnan Li, Panpan Chen, Yanqiu Gu, Shaozhan Wang, Lei Wang, Chun Chen, Rong Wang, Yongfang Yuan. Salvianolic acid B inhibits hepatic stellate cell activation and liver fibrosis by targeting PDGFRβ. International Immunopharmacology 2023; 122: 110550 doi: 10.1016/j.intimp.2023.110550
|
| 253 |
Jianlin He, Kaikai Bai, Bihong Hong, Feng Zhang, Shizhong Zheng. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats. International Immunopharmacology 2017; 53: 56 doi: 10.1016/j.intimp.2017.09.013
|
| 254 |
Mariia Zadorozhna, Sante Di Gioia, Massimo Conese, Domenica Mangieri. Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment. Molecular Biology Reports 2020; 47(3): 2279 doi: 10.1007/s11033-020-05290-0
|
| 255 |
Samar M. Alhusseiny, Samar N. El-Beshbishi, Maha M. Abu Hashim, Hosam El-dein E. El-nemr, Aya E. Handoussa. Effectiveness of vinpocetine and isosorbide-5-mononitrate on experimental schistosomiasis mansoni: Biochemical and immunohistochemical study. Acta Tropica 2018; 186: 16 doi: 10.1016/j.actatropica.2018.06.010
|
| 256 |
Yusheng Zhao, Hui Kong, Yuru Li, Yafang Zhao, Yue Zhang, Yan Zhao, Huihua Qu.
Inhibitory effects of
Curcumae Radix carbonisata
-based carbon dots against liver fibrosis induced by carbon tetrachloride in mice
. Artificial Cells, Nanomedicine, and Biotechnology 2024; 52(1): 23 doi: 10.1080/21691401.2023.2239522
|
| 257 |
Shan Li, Fangmin Song, Xu Lei, Jingtao Li, Fang Li, Huabing Tan. hsa_circ_0004018 suppresses the progression of liver fibrosis through regulating the hsa-miR-660-3p/TEP1 axis. Aging 2020; 12(12): 11517 doi: 10.18632/aging.103257
|
| 258 |
Xin Deng, Xing-Qiu Liang, Fei-Guo Lu, Xiao-Fang Zhao, Lei Fu, Jian Liang. Metabolomic profiling for identification of metabolites and relevant pathways for taurine in hepatic stellate cells. World Journal of Gastroenterology 2017; 23(31): 5713-5721 doi: 10.3748/wjg.v23.i31.5713
|
| 259 |
Sanne Van Campenhout, Hans Van Vlierberghe, Lindsey Devisscher. Experimental Cholestasis Research. Methods in Molecular Biology 2019; 1981: 237 doi: 10.1007/978-1-4939-9420-5_15
|
| 260 |
Li Li, Lei Zhang, Xiongqi Zhao, Jun Cao, Jingfeng Li, Guang Chu. Downregulation of miR‑152 contributes to the progression of liver fibrosis via targeting Gli3 in�vivo and in�vitro. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7595
|
| 261 |
Soudeh Moghadasi, Marischa Elveny, Heshu Sulaiman Rahman, Wanich Suksatan, Abduladheem Turki Jalil, Walid Kamal Abdelbasset, Alexei Valerievich Yumashev, Siavash Shariatzadeh, Roza Motavalli, Farahnaz Behzad, Faroogh Marofi, Ali Hassanzadeh, Yashwant Pathak, Mostafa Jarahian. A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02980-6
|
| 262 |
Longfei Ren, Kuo Qi, Lei Zhang, Zhongtian Bai, Chenghui Ren, Xianyun Xu, Zeliang Zhang, Xun Li. Glutathione Might Attenuate Cadmium-Induced Liver Oxidative Stress and Hepatic Stellate Cell Activation. Biological Trace Element Research 2019; 191(2): 443 doi: 10.1007/s12011-019-1641-x
|
| 263 |
Deping Cao, Emad Shamsan, Bofan Jiang, Haining Fan, Yaogang Zhang, Mustafa Abdo Saif Dehwah. Structural changes and expression of hepatic fibrosis-related proteins in coculture of Echinococcus multilocularis protoscoleces and human hepatic stellate cells. Parasites & Vectors 2021; 14(1) doi: 10.1186/s13071-021-05037-1
|
| 264 |
Jiayin Chang, Congying Huang, Siqi Li, Xiaolei Jiang, Hong Chang, Minhui Li. Research Progress Regarding the Effect and Mechanism of Dietary Polyphenols in Liver Fibrosis. Molecules 2023; 29(1): 127 doi: 10.3390/molecules29010127
|
| 265 |
Xin Yu Liu, Dan Li, Tian Yang Li, Yan-Ling Wu, Jing shu Piao, Ming Guan Piao. Vitamin A - modified Betulin polymer micelles with hepatic targeting capability for hepatic fibrosis protection. European Journal of Pharmaceutical Sciences 2022; 174: 106189 doi: 10.1016/j.ejps.2022.106189
|
| 266 |
Fang-Tian Bu, Yu Chen, Hai-Xia Yu, Xin Chen, Yang Yang, Xue-Yin Pan, Qin Wang, Yu-Ting Wu, Cheng Huang, Xiao-Ming Meng, Jun Li. SENP2 alleviates CCl4-induced liver fibrosis by promoting activated hepatic stellate cell apoptosis and reversion. Toxicology Letters 2018; 289: 86 doi: 10.1016/j.toxlet.2018.03.010
|
| 267 |
I. A. Karabak, D. Yu. Lobzin, V. E. Karev. Clinical and immunomorphological predictors of the adverse course of chronic hepatitis C. Journal Infectology 2020; 12(2): 79 doi: 10.22625/2072-6732-2020-12-2-79-87
|
| 268 |
Soudeh Ghafouri-Fard, Arian Askari, Alireza Zangooie, Hamed Shoorei, Hasan Pourmoshtagh, Mohammad Taheri. Non-coding RNA profile for natural killer cell activity. Molecular and Cellular Probes 2023; 72: 101935 doi: 10.1016/j.mcp.2023.101935
|
| 269 |
Sheng Tang, Yinghong Li, Yunyang Bao, Zhiting Dai, Tianyu Niu, Kun Wang, Hongwei He, Danqing Song. Novel cytisine derivatives exert anti-liver fibrosis effect via PI3K/Akt/Smad pathway. Bioorganic Chemistry 2019; 90: 103032 doi: 10.1016/j.bioorg.2019.103032
|
| 270 |
Qing Liang, Yudi Hu, Meina Zhang, Chunjie Lin, Wei Zhang, Ying Li, Ping Zhu, Pengxin Xue, Yujie Chen, Qiyuan Li, Kejia Wang. The T Cell Receptor Immune Repertoire Protects the Liver From Reconsitution. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.584979
|
| 271 |
Xiaohe Li, Hailong Li, Shanshan Zhang, Ruotong Zhang, Jinhe Li, Yiying Wei, Cheng Yang, Fubo Zhang, Honggang Zhou. Protective effect of Idelalisib on carbon tetrachloride‐induced liver fibrosis via microRNA‐124‐3P/phosphatidylinositol‐3‐hydroxykinase signalling pathway. Journal of Cellular and Molecular Medicine 2021; 25(24): 11185 doi: 10.1111/jcmm.17039
|
| 272 |
Zhenni Liu, Xue Wu, Qi Wang, Zixuan Li, Xueqi Liu, Xiaodong Sheng, Hong Zhu, Mengda Zhang, Junrui Xu, Xiaowen Feng, Baoming Wu, Xiongwen Lv. CD73-Adenosine A1R Axis Regulates the Activation and Apoptosis of Hepatic Stellate Cells Through the PLC-IP3-Ca2+/DAG-PKC Signaling Pathway. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.922885
|
| 273 |
Jie Zhang, Yu Liu, Haiqiang Chen, Qi Yuan, Jinyan Wang, Meng Niu, Lingling Hou, Jianchun Gu, Jinhua Zhang. MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization. Cell Death & Disease 2022; 13(4) doi: 10.1038/s41419-022-04802-z
|
| 274 |
Zi-bo Li, Lin Jiang, Jia-dong Ni, Yuan-hang Xu, Fang Liu, Wen-ming Liu, Shao-gui Wang, Zhong-qiu Liu, Cai-yan Wang. Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells. Acta Pharmacologica Sinica 2023; 44(6): 1191 doi: 10.1038/s41401-022-01044-9
|
| 275 |
Matthew Brovold, Dale Keller, Shay Soker. Differential fibrotic phenotypes of hepatic stellate cells within 3D liver organoids. Biotechnology and Bioengineering 2020; 117(8): 2516 doi: 10.1002/bit.27379
|
| 276 |
Xuan Zhou, Jun Xiong, Shi Lu, Lei Luo, Zhi-Lin Chen, Fan Yang, Feng Jin, Yao Wang, Qian Ma, Ying-Ying Luo, Yu-Jie Wang, Jia-Bin Zhou, Pan Liu, Lei Zhao. Inhibitory Effect of Corilagin on miR-21-Regulated Hepatic Fibrosis Signaling Pathway. The American Journal of Chinese Medicine 2019; 47(07): 1541 doi: 10.1142/S0192415X19500794
|
| 277 |
Qiang Yu, Ping Cheng, Jianye Wu, Chuanyong Guo. PPARγ/NF‐κB and TGF‐β1/Smad pathway are involved in the anti‐fibrotic effects of levo‐tetrahydropalmatine on liver fibrosis. Journal of Cellular and Molecular Medicine 2021; 25(3): 1645 doi: 10.1111/jcmm.16267
|
| 278 |
Yusheng Liu, Yihan Lyu, Lijuan Zhu, Hongmei Wang. Role of TRP Channels in Liver-Related Diseases. International Journal of Molecular Sciences 2023; 24(15): 12509 doi: 10.3390/ijms241512509
|
| 279 |
Grégorie Lebeau, Franck Ah-Pine, Matthieu Daniel, Yosra Bedoui, Damien Vagner, Etienne Frumence, Philippe Gasque. Perivascular Mesenchymal Stem/Stromal Cells, an Immune Privileged Niche for Viruses?. International Journal of Molecular Sciences 2022; 23(14): 8038 doi: 10.3390/ijms23148038
|
| 280 |
Qianqian Zhao, Luhua Liang, Fei Zhai, Guixia Ling, Rongwu Xiang, Xiwei Jiang. A bibliometric and visualized analysis of liver fibrosis from 2002 to 2022. Journal of Gastroenterology and Hepatology 2023; 38(3): 359 doi: 10.1111/jgh.16081
|
| 281 |
Xiaowei Wang, Wenjun Zhang, Sheng Zeng, Liudi Wang, Bin Wang. Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy. Acta Biomaterialia 2024; 175: 262 doi: 10.1016/j.actbio.2023.12.027
|
| 282 |
Narges Mohammadtaghvaei, Reza Afarin, Fatemeh Mavalizadeh, Elham Shakerian, Samaneh Salehipour Bavarsad, Ghorban Mohammadzadeh. Effect of Quercetin on the Expression of NOXs and P-Smad3C in TGF-Β-Activated Hepatic Stellate Cell Line LX-2. Hepatitis Monthly 2021; 21(6) doi: 10.5812/hepatmon.116875
|
| 283 |
Nesma A. Abd Elrazik, Mohamed El-Mesery, Mamdouh M. El-Shishtawy. Sesamol protects against liver fibrosis induced in rats by modulating lysophosphatidic acid receptor expression and TGF-β/Smad3 signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 2022; 395(8): 1003 doi: 10.1007/s00210-022-02259-7
|
| 284 |
Dengcheng Hui, Lu Liu, Yanqin Bian, Nisma L. B. Azami, Jingru Song, Yanping Huang, Mingyu Sun. Traditional Chinese medicine targets on hepatic stellate cells for the treatment of hepatic fibrosis: A mechanistic review. Portal Hypertension & Cirrhosis 2023; 2(1): 16 doi: 10.1002/poh2.36
|
| 285 |
Farooq Riaz, Qian Chen, Kaikai Lu, Ezra Kombo Osoro, Litao Wu, Lina Feng, Rong Zhao, Luyun Yang, Yimeng Zhou, Yingli He, Li Zhu, Xiaojuan Du, Muhammad Sadiq, Xudong Yang, Dongmin Li. Inhibition of miR‐188‐5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway. Journal of Cellular and Molecular Medicine 2021; 25(8): 4073 doi: 10.1111/jcmm.16376
|
| 286 |
Guohua Fan, Yang Ya, Xiaoqiong Ni, Jinpeng Hou, Rui Yu. Application Value of Magnetic Resonance Perfusion Imaging in the Early Diagnosis of Rat Hepatic Fibrosis. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/5095934
|
| 287 |
Zhuyun Xing, Yayun Wu, Na Liu. IL‑22 alleviates the fibrosis of hepatic stellate cells via the inactivation of NLRP3 inflammasome signaling. Experimental and Therapeutic Medicine 2021; 22(4) doi: 10.3892/etm.2021.10522
|
| 288 |
Fanrui Meng, Mir Hassan Khoso, Kai Kang, Qi He, Yukai Cao, Xinghao Jiang, Wei Xiao, Deshan Li. FGF21 ameliorates hepatic fibrosis by multiple mechanisms. Molecular Biology Reports 2021; 48(11): 7153 doi: 10.1007/s11033-021-06707-0
|
| 289 |
Xue Wang, Ling Song, Yan Zhuang, Lin Han, Ke Chen, Jiangli Lin, Yan Luo. A Hierarchical Siamese Network for Noninvasive Staging of Liver Fibrosis Based on US Image Pairs of the Liver and Spleen. Sensors 2023; 23(12): 5450 doi: 10.3390/s23125450
|
| 290 |
Yeonhwa Song, Sanghwa Kim, Jinyeong Heo, David Shum, Su-Yeon Lee, Minji Lee, A-Ram Kim, Haeng Ran Seo. Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-90263-x
|
| 291 |
Yarong Zhao, Yang Yu, Simiao Wang, Jiaxin Li, Lesheng Teng. Small extracellular vesicles encapsulating lefty1 mRNA inhibit hepatic fibrosis. Asian Journal of Pharmaceutical Sciences 2022; 17(5): 630 doi: 10.1016/j.ajps.2022.07.004
|
| 292 |
Lili Zhang, Qiumei Zhou, Jiafu Zhang, Kefeng Cao, Chang Fan, Sen Chen, Hui Jiang, Furong Wu. Liver transcriptomic and proteomic analyses provide new insight into the pathogenesis of liver fibrosis in mice. Genomics 2023; 115(6): 110738 doi: 10.1016/j.ygeno.2023.110738
|
| 293 |
Guangwen Shu, Chenxi Dai, Arslan Yusuf, Hui Sun, Xukun Deng. Limonin relieves TGF-β-induced hepatocyte EMT and hepatic stellate cell activation in vitro and CCl4-induced liver fibrosis in mice via upregulating Smad7 and subsequent suppression of TGF-β/Smad cascade. The Journal of Nutritional Biochemistry 2022; 107: 109039 doi: 10.1016/j.jnutbio.2022.109039
|
| 294 |
Zhenlong Yu, Yanan Jv, Lu Cai, Xiangge Tian, Xiaokui Huo, Chao Wang, Baojing Zhang, ChengPeng Sun, Jing Ning, Lei Feng, Houli Zhang, Xiaochi Ma. Gambogic acid attenuates liver fibrosis by inhibiting the PI3K/AKT and MAPK signaling pathways via inhibiting HSP90. Toxicology and Applied Pharmacology 2019; 371: 63 doi: 10.1016/j.taap.2019.03.028
|
| 295 |
Halyna Kuznietsova, Natalia Dziubenko, Vasyl Hurmach, Iryna Chereschuk, Olexandr Motuziuk, Olexandr Ogloblya, Yuriy Prylutskyy. Water-Soluble Pristine C60 Fullerenes Inhibit Liver Fibrotic Alteration and Prevent Liver Cirrhosis in Rats. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/8061246
|
| 296 |
Reza Heidari, M. Mehdi Ommati. Taurine and the Mitochondrion: Applications in the Pharmacotherapy of Human Diseases. 2023; : 108 doi: 10.2174/9789815124484123010007
|
| 297 |
Li-Ye Zhang, Yong Tan, Xiao-Jie Luo, Jiang-Feng Wu, Yi-Ran Ni. The roles of ETS transcription factors in liver fibrosis. Human Cell 2022; 36(2): 528 doi: 10.1007/s13577-022-00848-5
|
| 298 |
Silja H. Voutilainen, Silja K. Kosola, Jouko Lohi, Timo Jahnukainen, Mikko P. Pakarinen, Hannu Jalanko. Expression of fibrosis‐related genes in liver allografts: Association with histology and long‐term outcome after pediatric liver transplantation. Clinical Transplantation 2021; 35(8) doi: 10.1111/ctr.14373
|
| 299 |
Bahare Niknam, Kaveh Baghaei, Seyed Mahmoud Hashemi, Behzad Hatami, Mohammad Reza Zali, Davar Amani. Human Wharton’s jelly mesenchymal stem cells derived-exosomes enriched by miR-124 promote an anti-fibrotic response in an experimental model of liver fibrosis. International Immunopharmacology 2023; 119: 110294 doi: 10.1016/j.intimp.2023.110294
|
| 300 |
Thikryat Neamatallah, Ashraf B. Abdel-Naim, Basma G. Eid, Atif Hasan. 2-Methoxyestradiol attenuates liver fibrosis in mice: implications for M2 macrophages. Naunyn-Schmiedeberg's Archives of Pharmacology 2019; 392(3): 381 doi: 10.1007/s00210-018-1577-2
|
| 301 |
Young-Chan Yoon, Zhenghuan Fang, Ji Eun Lee, Jung Hee Park, Ji-Kan Ryu, Kyung Hee Jung, Soon-Sun Hong. Selonsertib Inhibits Liver Fibrosis via Downregulation of ASK1/ MAPK Pathway of Hepatic Stellate Cells. Biomolecules & Therapeutics 2020; 28(6): 527 doi: 10.4062/biomolther.2020.016
|
| 302 |
Carina Wagner, Victoria Hois, Laura Pajed, Lisa-Maria Pusch, Heimo Wolinski, Michael Trauner, Robert Zimmermann, Ulrike Taschler, Achim Lass. Lysosomal acid lipase is the major acid retinyl ester hydrolase in cultured human hepatic stellate cells but not essential for retinyl ester degradation. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(8): 158730 doi: 10.1016/j.bbalip.2020.158730
|
| 303 |
Rafael Cierpka, Ralf Weiskirchen, Anastasia Asimakopoulos. Perilipin 5 Ameliorates Hepatic Stellate Cell Activation via SMAD2/3 and SNAIL Signaling Pathways and Suppresses STAT3 Activation. Cells 2021; 10(9): 2184 doi: 10.3390/cells10092184
|
| 304 |
Baozhang Shi, Jinqiang Qian, Hongyue Miao, Shuo Zhang, Yue Hu, Puqing Liu, Liping Xu. Mulberroside A ameliorates CCl4‐induced liver fibrosis in mice via inhibiting pro‐inflammatory response. Food Science & Nutrition 2023; 11(6): 3433 doi: 10.1002/fsn3.3333
|
| 305 |
Mark Li, Ling Yang. Autophagy in Health and Disease. 2022; : 161 doi: 10.1016/B978-0-12-822003-0.00014-0
|
| 306 |
Nazli Khodayari, Regina Oshins, L. Shannon Holliday, Virginia Clark, Qiang Xiao, George Marek, Borna Mehrad, Mark Brantly. Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargo. Cell Communication and Signaling 2020; 18(1) doi: 10.1186/s12964-020-00648-0
|
| 307 |
Yazhou Li, Peixiao Liu, Feipeng Wei. Long non‑coding RNA MBI‑52 inhibits the development of liver fibrosis by regulating the microRNA‑466g/SMAD4 signaling pathway. Molecular Medicine Reports 2021; 25(1) doi: 10.3892/mmr.2021.12549
|
| 308 |
Yong Zhang, Hao Li, Zhijian Xu, Yulong Shi, Bo Li, Jia Li, Haji Akber Aisa, Yi Zang, Weiliang Zhu. Three new feruloyl glucuronopyranosyl glycerols from Eriocaulon buergerianum with their anti-fibrotic effects on hepatic stellate cells. Natural Product Research 2023; 37(6): 956 doi: 10.1080/14786419.2022.2099387
|
| 309 |
Thomas G. Bird, Christos Kiourtis. Cellular Senescence in Disease. 2022; : 107 doi: 10.1016/B978-0-12-822514-1.00004-3
|
| 310 |
Hai-Feng Liu, Qing Wang, Ya-Nan Du, Zu-Hui Zhu, Yu-Feng Li, Li-Qiu Zou, Wei Xing. Dynamic contrast-enhanced MRI with Gd-EOB-DTPA for the quantitative assessment of early-stage liver fibrosis induced by carbon tetrachloride in rabbits. Magnetic Resonance Imaging 2020; 70: 57 doi: 10.1016/j.mri.2020.04.010
|
| 311 |
Maryam Saadat, Farid Mostafaei, Somaye Mahdinloo, Mahdieh Abdi, Fahimeh Zahednezhad, Parvin Zakeri-Milani, Hadi Valizadeh. Drug delivery of pH-Sensitive nanoparticles into the liver cancer cells. Journal of Drug Delivery Science and Technology 2021; 63: 102557 doi: 10.1016/j.jddst.2021.102557
|
| 312 |
Xiaolei Sun, Li Zhang, Yuting Jiang, Aihong Li, Dandan Zhu, Jiangrong Wu, Yinong Duan, Matty Knight. The role of let-7b in the inhibition of hepatic stellate cell activation by rSjP40. PLOS Neglected Tropical Diseases 2021; 15(6): e0009472 doi: 10.1371/journal.pntd.0009472
|
| 313 |
Yan-Zhen Zhang, Jian-Ning Yao, Lian-Feng Zhang, Chun-Feng Wang, Xue-Xiu Zhang, Bing Gao. Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway. World Journal of Gastroenterology 2019; 25(24): 3044-3055 doi: 10.3748/wjg.v25.i24.3044
|
| 314 |
Connie Hung, Eleonora Napoli, Catherine Ross-Inta, James Graham, Amanda L. Flores-Torres, Kimber L. Stanhope, Pascal Froment, Peter J. Havel, Cecilia Giulivi. Ileal interposition surgery targets the hepatic TGF‐β pathway, influencing gluconeogenesis and mitochondrial bioenergetics in the UCD‐T2DM rat model of diabetes. The FASEB Journal 2019; 33(10): 11270 doi: 10.1096/fj.201802714R
|
| 315 |
Karthik Shree Harini, Devaraj Ezhilarasan. Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases. Hepatobiliary & Pancreatic Diseases International 2023; 22(4): 333 doi: 10.1016/j.hbpd.2022.10.003
|
| 316 |
Tianyuan Zhao, Zixinying Han, Jiamin Zhang, Ying Ding, Jingjing Chen, Hailing Qiao, Na Gao. Effect of ADHI on hepatic stellate cell activation and liver fibrosis in mice. Biochemical and Biophysical Research Communications 2023; 651: 98 doi: 10.1016/j.bbrc.2023.02.008
|
| 317 |
Claudia Sîrbe, Medeea Badii, Tania O. Crişan, Gabriel Bența, Alina Grama, Leo A. B. Joosten, Simona Rednic, Tudor Lucian Pop. Detection of Novel Biomarkers in Pediatric Autoimmune Hepatitis by Proteomic Profiling. International Journal of Molecular Sciences 2023; 24(8): 7479 doi: 10.3390/ijms24087479
|
| 318 |
Yitong Zhang, Jing Liu, Yanyun Ma, Jingjie Wang, Jie Zhu, Jie Liu, Jun Zhang. Integration of high‑throughput data of microRNA and mRNA expression profiles reveals novel insights into the mechanism of liver fibrosis. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9641
|
| 319 |
Ayobami Dare, Skylar D. King, Shi-You Chen. Surfactant protein A promotes western diet-induced hepatic steatosis and fibrosis in mice. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-58291-5
|
| 320 |
Ya-ru Yang, Fang-tian Bu, Yang Yang, Hao Li, Cheng Huang, Xiao-ming Meng, Lei Zhang, Xiong-wen Lv, Jun Li. LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway. Molecular Immunology 2020; 126: 31 doi: 10.1016/j.molimm.2020.07.012
|
| 321 |
Liang'en Chen, Xiangshi Ye, Lixian Yang, Jiangsha Zhao, Jia You, Yuxiong Feng. Linking fatty liver diseases to hepatocellular carcinoma by hepatic stellate cells. Journal of the National Cancer Center 2024; 4(1): 25 doi: 10.1016/j.jncc.2024.01.002
|
| 322 |
Jinyuan Hu, Yuanyuan Liu, Zheng Pan, Xuekuan Huang, Jianwei Wang, Wenfu Cao, Zhiwei Chen. Eupatilin Ameliorates Hepatic Fibrosis and Hepatic Stellate Cell Activation by Suppressing β-catenin/PAI-1 Pathway. International Journal of Molecular Sciences 2023; 24(6): 5933 doi: 10.3390/ijms24065933
|
| 323 |
Philip O’Gorman, Sara Naimimohasses, Ann Monaghan, Megan Kennedy, Ashanty M. Melo, Deirdre Ní Fhloinn, Derek G. Doherty, Peter Beddy, Stephen P. Finn, J. Bernadette Moore, John Gormley, Suzanne Norris. Improvement in histological endpoints of MAFLD following a 12‐week aerobic exercise intervention. Alimentary Pharmacology & Therapeutics 2020; 52(8): 1387 doi: 10.1111/apt.15989
|
| 324 |
Kenneth M. Adusei, Tran B. Ngo, Kaitlyn Sadtler. T lymphocytes as critical mediators in tissue regeneration, fibrosis, and the foreign body response. Acta Biomaterialia 2021; 133: 17 doi: 10.1016/j.actbio.2021.04.023
|
| 325 |
Anshika Jangra, Ashish Kothari, Phulen Sarma, Bikash Medhi, Balram Ji Omar, Karanvir Kaushal. Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis. Cells 2022; 11(9): 1500 doi: 10.3390/cells11091500
|
| 326 |
B. Alipoor, S. Nikouei, F. Rezaeinejad, S-N. Malakooti-Dehkordi, Z. Sabati, H. Ghasemi. Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets. Journal of Endocrinological Investigation 2021; 44(10): 2015 doi: 10.1007/s40618-021-01559-8
|
| 327 |
Philip Dalsbecker, Caroline Beck Adiels, Mattias Goksör. Liver-on-a-chip devices: the pros and cons of complexity. American Journal of Physiology-Gastrointestinal and Liver Physiology 2022; 323(3): G188 doi: 10.1152/ajpgi.00346.2021
|
| 328 |
Bo Zhu, Siu-Lung Chan, Jack Li, Kathryn Li, Hao Wu, Kui Cui, Hong Chen. Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.742382
|
| 329 |
Dong Ji, Guo-Feng Chen, Jin-Cheng Wang, Si-Han Ji, Xue-Wen Wu, Xiao-Jie Lu, Jin-Lian Chen, Jing-Tao Li. Hsa_circ_0070963 inhibits liver fibrosis via regulation of miR-223-3p and LEMD3. Aging 2020; 12(2): 1643 doi: 10.18632/aging.102705
|
| 330 |
Junxiong Cheng, Zhiwei Chen, Guoqing Zuo, Wenfu Cao. Integrated analysis of differentially expressed genes, differentially methylated genes, and natural compounds in hepatitis C virus-induced cirrhosis. Journal of International Medical Research 2022; 50(1): 030006052210745 doi: 10.1177/03000605221074525
|
| 331 |
Yong Li, Xu-Lin He, Li-Ping Zhou, Xiao-Zhong Huang, Shan Li, Su Guan, Jing Li, Lei Zhang. Asiatic acid alleviates liver fibrosis via multiple signaling pathways based on integrated network pharmacology and lipidomics. European Journal of Pharmacology 2022; 931: 175193 doi: 10.1016/j.ejphar.2022.175193
|
| 332 |
You-Li Yao, Xin Han, Jian Song, Jing Zhang, Ya-Mei Li, Li-Hua Lian, Yan-Ling Wu, Ji-Xing Nan. Acanthoic acid protectsagainst ethanol-induced liver injury: Possible role of AMPK activation and IRAK4 inhibition. Toxicology Letters 2017; 281: 127 doi: 10.1016/j.toxlet.2017.09.020
|
| 333 |
Wei Peng, Shiwen Zhang, Wei Zhou, Xinchen Zhao, Kexue Wang, Chengxu Yue, Xinyu Wei, Siyan Pang, Wei Dong, Sulian Chen, Changjie Chen, Qingling Yang, Wenrui Wang. Layered Double Hydroxides-Loaded Sorafenib Inhibit Hepatic Stellate Cells Proliferation and Activation In Vitro and Reduce Fibrosis In Vivo. Frontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.873971
|
| 334 |
Esraa Ali, Andriy Trailin, Filip Ambrozkiewicz, Václav Liška, Kari Hemminki. Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies. International Journal of Molecular Sciences 2022; 23(23): 15292 doi: 10.3390/ijms232315292
|
| 335 |
Dapeng Wang, Huifen Xu, Lili Fan, Wenli Ruan, Qian Song, Heng Diao, Rui He, Ying Jin. Hyperphosphorylation of EGFR/ERK signaling facilitates long-term arsenite-induced hepatocytes epithelial-mesenchymal transition and liver fibrosis in sprague-dawley rats. Ecotoxicology and Environmental Safety 2023; 249: 114386 doi: 10.1016/j.ecoenv.2022.114386
|
| 336 |
Masatsugu Ohara, Shunsuke Ohnishi, Hidetaka Hosono, Koji Yamamoto, Qingjie Fu, Osamu Maehara, Goki Suda, Naoya Sakamoto. Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00709
|
| 337 |
ZongYang Wu, JinBo Wang, JiYe Feng, LiPing Ying. MicroRNA-122-5p prevents proliferation and promotes apoptosis of hepatic stellate cells by suppressing the cellular-Abelsongene/histone deacetylases 2 pathway. Human & Experimental Toxicology 2022; 41: 096032712210846 doi: 10.1177/09603271221084672
|
| 338 |
Hui Jiang, Congying Chen, Jun Gao. Extensive Summary of the Important Roles of Indole Propionic Acid, a Gut Microbial Metabolite in Host Health and Disease. Nutrients 2022; 15(1): 151 doi: 10.3390/nu15010151
|
| 339 |
Meysam Ramezani, Mahsa Zobeiry, Shahrokh Abdolahi, Behzad Hatami, Mohammad Reza Zali, Kaveh Baghaei. A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression. Pathology - Research and Practice 2023; 251: 154809 doi: 10.1016/j.prp.2023.154809
|
| 340 |
Matthias Van Haele, Janne Snoeck, Tania Roskams. Human Liver Regeneration: An Etiology Dependent Process. International Journal of Molecular Sciences 2019; 20(9): 2332 doi: 10.3390/ijms20092332
|
| 341 |
Anna Rossetto, Valli De Re, Agostino Steffan, Matteo Ravaioli, Gianmaria Miolo, Patrizia Leone, Vito Racanelli, Alessandro Uzzau, Umberto Baccarani, Matteo Cescon. Carcinogenesis and Metastasis in Liver: Cell Physiological Basis. Cancers 2019; 11(11): 1731 doi: 10.3390/cancers11111731
|
| 342 |
Jin-Jin Dai, Ya-Fei Zhang, Zhen-Hua Zhang. Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023). World Journal of Gastroenterology 2023; 29(37): 5339-5360 doi: 10.3748/wjg.v29.i37.5339
Abstract(291) |
Core Tip(277) |
Full Article(HTML)(2354)
|
Full Article with Cover (PDF)-23362K(70)
|
Full Article (Word)-2780K(33)
|
Audio-879K(2)
|
Peer-Review Report-223K(40)
|
Answering Reviewers-102K(27)
|
Full Article (PDF)-21753K(179)
|
Full Article (XML)-304K(28)
|
Times Cited (2)
|
Total Visits (4574)
|
Open
|
| 343 |
Erika Ramos-Tovar, Sael Casas-Grajales, Erika Hernández-Aquino, Rosa E. Flores-Beltrán, Silvia Galindo-Gómez, Eunice Vera-Aguilar, Araceli Diaz-Ruiz, Sergio Montes, Javier Camacho, Víctor Tsutsumi, Pablo Muriel. Cirrhosis induced by thioacetamide is prevented by stevia. Molecular mechanisms. Journal of Functional Foods 2019; 52: 552 doi: 10.1016/j.jff.2018.11.039
|
| 344 |
Marina Badenes, Colin Adrain. iRhom2 and TNF: Partners or enemies?. Science Signaling 2019; 12(605) doi: 10.1126/scisignal.aaz0444
|
| 345 |
Nicolás Salva-Pastor, Guillermo Nahúm López-Sánchez, Norberto Carlos Chávez-Tapia, Jorge Román Audifred-Salomón, Danniela Niebla-Cárdenas, Rafael Topete-Estrada, Helga Pereznuñez-Zamora, Rafael Vidaltamayo-Ramírez, Margarita Elodia Báez-Arellano, Misael Uribe, Natalia Nuño-Lámbarri. Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population. Annals of Hepatology 2020; 19(3): 251 doi: 10.1016/j.aohep.2020.01.004
|
| 346 |
Li-Jun Song, Xu-Ren Yin, Sha-Sha Mu, Jia-Huang Li, Hong Gao, Ying Zhang, Pan-Pan Dong, Cong-Jin Mei, Zi-Chun Hua. The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in Mice. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.570524
|
| 347 |
Jin-Pei Liu, Shao-Hua Song, Pei-Mei Shi, Xiao-Yu Qin, Bai-Nan Zheng, Shu-Qing Liu, Chen-Hong Ding, Xin Zhang, Wei-Fen Xie, Yi-Hai Shi, Wen-Ping Xu. miR-541 is associated with the prognosis of liver cirrhosis and directly targets JAG2 to inhibit the activation of hepatic stellate cells. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03174-2
|
| 348 |
Yiming Zhu, Chihao Zhang, Mingzhe Huang, Jiayun Lin, Xiao Fan, Tao Ni. TRIM26 Induces Ferroptosis to Inhibit Hepatic Stellate Cell Activation and Mitigate Liver Fibrosis Through Mediating SLC7A11 Ubiquitination. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.644901
|
| 349 |
Xia Niu, Xiaomei Wang, Bingyu Niu, Yucheng Wang, Hongwei He, Guiling Li. New IMB16-4 Nanoparticles Improved Oral Bioavailability and Enhanced Anti-Hepatic Fibrosis on Rats. Pharmaceuticals 2022; 15(1): 85 doi: 10.3390/ph15010085
|
| 350 |
Zixuan Li, Xiaoying Wu, Zebin Chen, Xiuqing Wei, Weiqing Chen. Association between low-normal thyroid function and advanced liver fibrosis in metabolic dysfunction-associated fatty liver disease patients: a retrospective cohort study. Gastroenterology Report 2023; 12 doi: 10.1093/gastro/goad076
|
| 351 |
Mi Jin Choi, Hana Yu, Jea Il Kim, Hee Seo, Ju Gyeong Kim, Seul-Ki Kim, Hak Sung Lee, Hyae Gyeong Cheon. Anti-obesity effects of Lactiplantibacillus plantarum SKO-001 in high-fat diet-induced obese mice. European Journal of Nutrition 2023; 62(4): 1611 doi: 10.1007/s00394-023-03096-x
|
| 352 |
Qianglin Chen, Jianqiang Zhang, Ting Zheng, Hui Chen, Hao Nie, Bing Zheng, Quan Gong. The role of microRNAs in the pathogenesis, grading and treatment of hepatic fibrosis in schistosomiasis. Parasites & Vectors 2019; 12(1) doi: 10.1186/s13071-019-3866-0
|
| 353 |
Guangyan Wang, Jinjie Duan, Guangyin Pu, Chenji Ye, Yue Li, Wenjing Xiu, Jingwen Xu, Ben Liu, Yi Zhu, Chunjiong Wang. The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022; 1868(8): 166413 doi: 10.1016/j.bbadis.2022.166413
|
| 354 |
Yuwei Zhang, Yang Li, Tong Mu, Nanwei Tong, Ping Cheng. Hepatic stellate cells specific liposomes with the Toll‐like receptor 4 shRNA attenuates liver fibrosis. Journal of Cellular and Molecular Medicine 2021; 25(2): 1299 doi: 10.1111/jcmm.16209
|
| 355 |
Chao He, Bo Shu, Yingxia Zhou, Ruizhi Zhang, Xin Yang. The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl4-induced hepatic fibrosis in mice. Life Sciences 2021; 276: 119294 doi: 10.1016/j.lfs.2021.119294
|
| 356 |
Jibeom Lee, Hyeonhui Kim, Yun-Won Kang, Yumin Kim, Moon-young Park, Ji-Hong Song, Yunju Jo, Tam Dao, Dongryeol Ryu, Junguee Lee, Chang-Myung Oh, Sangkyu Park. LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease. Experimental & Molecular Medicine 2023; 55(7): 1479 doi: 10.1038/s12276-023-01033-w
|
| 357 |
Jarren R. Oates, Keisuke Sawada, Daniel A. Giles, Pablo C. Alarcon, Michelle S.M.A. Damen, Sara Szabo, Traci E. Stankiewicz, Maria E. Moreno-Fernandez, Senad Divanovic. Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1095132
|
| 358 |
Yuan Guan, Annika Enejder, Meiyue Wang, Zhuoqing Fang, Lu Cui, Shih-Yu Chen, Jingxiao Wang, Yalun Tan, Manhong Wu, Xinyu Chen, Patrik K. Johansson, Issra Osman, Koshi Kunimoto, Pierre Russo, Sarah C. Heilshorn, Gary Peltz. A human multi-lineage hepatic organoid model for liver fibrosis. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-26410-9
|
| 359 |
Anatoly Bozhkov, Igor Ionov, Nataliia Kurhuzova, Anna Novikova, Оleg Katerynych, Rustam Akzhyhitov. Vitamin A intake forms resistance to hypervitaminosis A and affects the functional activity of the liver. Clinical Nutrition Open Science 2022; 41: 82 doi: 10.1016/j.nutos.2021.12.003
|
| 360 |
Yuan Guan, Gary Peltz. Hepatic organoids move from adolescence to maturity. Liver International 2024; doi: 10.1111/liv.15893
|
| 361 |
Xinghang Dai, Yujun Zeng, Hu Zhang, Zhongwei Gu, Qiyong Gong, Kui Luo. Advances on Nanomedicines for Diagnosis and Theranostics of Hepatic Fibrosis. Advanced NanoBiomed Research 2021; 1(7) doi: 10.1002/anbr.202000091
|
| 362 |
Yumei Liu, Fengming Tian, Jiaoyu Shan, Jian Gao, Bin Li, Jie Lv, Xuan Zhou, Xuanlin Cai, Hao Wen, Xiumin Ma. Kupffer Cells: Important Participant of Hepatic Alveolar Echinococcosis. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.00008
|
| 363 |
Jianhao Jiang, Ilgiz Gareev, Tatiana Ilyasova, Alina Shumadalova, Weijie Du, Baofeng Yang. The role of lncRNA-mediated ceRNA regulatory networks in liver fibrosis. Non-coding RNA Research 2024; 9(2): 463 doi: 10.1016/j.ncrna.2024.01.001
|
| 364 |
Mazhar A. Kanak, Yoshitaro Shindo, Pavithra SaiKumar, Bashoo Naziruddin. Inflammasomes: Clinical and Therapeutic Implications. Experientia Supplementum 2018; 108: 235 doi: 10.1007/978-3-319-89390-7_10
|
| 365 |
Yue Gao, Shicheng Fan, Pengfei Zhao, Huilin Li, Chenghui Cai, Xuan Li, Yanying Zhou, Min Huang, Huichang Bi. β-catenin/TCF4 inhibitors ICG-001 and LF3 alleviate BDL-induced liver fibrosis by suppressing LECT2 signaling. Chemico-Biological Interactions 2023; 371: 110350 doi: 10.1016/j.cbi.2023.110350
|
| 366 |
Mei-Ling Chang, Yu-Ting Lin, Hsiu-Ni Kung, Yu-Chen Hou, Jun-Jen Liu, Min-Hsiung Pan, Hui-Ling Chen, Chun-Hsien Yu, Po-Jung Tsai. A triterpenoid-enriched extract of bitter melon leaves alleviates hepatic fibrosis by inhibiting inflammatory responses in carbon tetrachloride-treated mice. Food & Function 2021; 12(17): 7805 doi: 10.1039/D1FO00884F
|
| 367 |
Stefan Hajny, Christina Christoffersen. A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation. International Journal of Molecular Sciences 2017; 18(8): 1636 doi: 10.3390/ijms18081636
|
| 368 |
Anupama Ariyaratne, Constance A. M. Finney, Andreas J. Bäumler. Eosinophils and Macrophages within the Th2-Induced Granuloma: Balancing Killing and Healing in a Tight Space. Infection and Immunity 2019; 87(10) doi: 10.1128/IAI.00127-19
|
| 369 |
Lei Ye, Yaping Yu, Yanping Zhao. Icariin‐induced miR‐875‐5p attenuates epithelial‐mesenchymal transition by targeting hedgehog signaling in liver fibrosis. Journal of Gastroenterology and Hepatology 2020; 35(3): 482 doi: 10.1111/jgh.14875
|
| 370 |
Shu Wang, Jianqiang Zhang, Hui Chen, Xiang Zhan, Hao Nie, Chao Wang, Yanxiang Zhang, Bing Zheng, Quan Gong. MicroRNA-181b promotes schistosomiasis-induced hepatic fibrosis by targeting Smad7. Molecular and Biochemical Parasitology 2022; 252: 111523 doi: 10.1016/j.molbiopara.2022.111523
|
| 371 |
Xin Han, YanLing Wu, Qiao Yang, Gang Cao. Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis. Pharmacology & Therapeutics 2021; 222: 107791 doi: 10.1016/j.pharmthera.2020.107791
|
| 372 |
Richell Booijink, Fernando Salgado‐Polo, Craig Jamieson, Anastassis Perrakis, Ruchi Bansal.
A type
IV
Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis
. EMBO Molecular Medicine 2022; 14(9) doi: 10.15252/emmm.202216333
|
| 373 |
LiQiu Zou, Hao Zhang, Qing Wang, WenXin Zhong, YaNan Du, HaiFeng Liu, Wei Xing. Simultaneous liver steatosis, fibrosis and iron deposition quantification with mDixon quant based on radiomics analysis in a rabbit model. Magnetic Resonance Imaging 2022; 94: 36 doi: 10.1016/j.mri.2022.08.013
|
| 374 |
Jialiang Luo, Lei Li, Bo Chang, Zhengyumeng Zhu, Fan Deng, Mengyao Hu, Yu Yu, Xiao Lu, Zhengliang Chen, Daming Zuo, Jia Zhou. Mannan-Binding Lectin via Interaction With Cell Surface Calreticulin Promotes Senescence of Activated Hepatic Stellate Cells to Limit Liver Fibrosis Progression. Cellular and Molecular Gastroenterology and Hepatology 2022; 14(1): 75 doi: 10.1016/j.jcmgh.2022.03.011
|
| 375 |
Tshimangadzo M. Denga, Sulè Gunter, Serena Fourie, Regina le Roux, Ashmeetha Manilall, Aletta M.E. Millen, Lebogang Mokotedi. Interleukin-6 Blockers Improve Inflammation-Induced Lipid Metabolism
Impairments but Induce Liver Fibrosis in Collagen-Induced Arthritis. Endocrine, Metabolic & Immune Disorders - Drug Targets 2023; 23(4): 548 doi: 10.2174/1871530323666221017153157
|
| 376 |
Bowen Li, Hui Wang, Yudian Zhang, Ying Liu, Tiejun Zhou, Bingru Zhou, Ying Zhang, Rong Chen, Juan Xing, Longfei He, Jennifer Mata Salinas, Sachiko Koyama, Fanyin Meng, Ying Wan. Current Perspectives of Neuroendocrine Regulation in Liver Fibrosis. Cells 2022; 11(23): 3783 doi: 10.3390/cells11233783
|